Role	O
of	O
cellular	B-protein
tumor	I-protein
necrosis	I-protein
factor	I-protein
receptor-associated	I-protein
factors	I-protein
in	O
NF-kappaB	B-protein
activation	O
and	O
lymphocyte	B-cell_type
transformation	O
by	O
herpesvirus	O
Saimiri	O
STP	B-protein
.	O

The	O
STP	B-protein
oncoproteins	I-protein
of	O
the	O
herpesvirus	O
saimiri	O
(	O
HVS	O
)	O
subgroup	O
A	O
strain	O
11	O
and	O
subgroup	O
C	O
strain	O
488	O
are	O
now	O
found	O
to	O
be	O
stably	O
associated	O
with	O
tumor	B-protein
necrosis	I-protein
factor	I-protein
receptor-associated	I-protein
factor	I-protein
(	I-protein
TRAF	I-protein
)	I-protein
1	I-protein
,	I-protein
2	I-protein
,	I-protein
or	I-protein
3	I-protein
.	O

Mutational	O
analyses	O
identified	O
residues	O
of	O
PXQXT/S	B-protein
in	O
STP-A11	B-protein
as	O
critical	O
for	O
TRAF	B-protein
association	O
.	O

In	O
addition	O
,	O
a	O
somewhat	O
divergent	O
region	O
of	O
STP-C488	B-protein
is	O
critical	O
for	O
TRAF	B-protein
association	O
.	O

Mutational	O
analysis	O
also	O
revealed	O
that	O
STP-C488	B-protein
induced	O
NF-kappaB	B-protein
activation	O
that	O
was	O
correlated	O
with	O
its	O
ability	O
to	O
associate	O
with	O
TRAFs	B-protein
.	O

The	O
HVS	O
STP-C488	B-protein
P10	O
--	O
>	O
R	O
mutant	O
was	O
deficient	O
in	O
human	O
T-lymphocyte	O
transformation	O
to	O
interleukin-2-independent	O
growth	O
but	O
showed	O
wild-type	O
phenotype	O
for	O
marmoset	O
T-lymphocyte	O
transformation	O
in	O
vitro	O
and	O
in	O
vivo	O
.	O

The	O
STP-C488	B-protein
P10	I-protein
--	I-protein
>	I-protein
R	I-protein
mutant	I-protein
was	O
also	O
defective	O
in	O
Rat-1	O
fibroblast	O
transformation	O
,	O
and	O
fibroblast	O
cell	O
transformation	O
was	O
blocked	O
by	O
a	O
TRAF2	B-protein
dominant-negative	O
mutant	O
.	O

These	O
data	O
implicate	O
TRAFs	B-protein
in	O
STP-C488	B-protein
-mediated	O
transformation	O
of	O
human	B-cell_type
lymphocytes	I-cell_type
and	O
rodent	O
fibroblasts	B-cell_type
.	O

Other	O
factors	O
are	O
implicated	O
in	O
immortalization	O
of	O
common	B-cell_type
marmoset	I-cell_type
T	I-cell_type
lymphocytes	I-cell_type
and	O
may	O
also	O
be	O
critical	O
in	O
the	O
transformation	O
of	O
human	B-cell_type
lymphocytes	I-cell_type
and	O
rodent	B-cell_type
fibroblasts	I-cell_type
.	O

JoUuRNAL	NULL
or	NULL
VirRoLOoGYy	NULL
,	NULL
May	NULL
1999	NULL
,	NULL
p.	NULL
3913-3919	NULL
0022-538	NULL
X/99/	NULL
$	NULL
04.00+0	NULL
Vol	NULL
.	NULL

73	NULL
,	NULL
No	NULL
.	NULL

5	NULL
Copyright	NULL
©	NULL
1999	NULL
,	NULL
American	NULL
Society	NULL
for	NULL
Microbiology	NULL
.	NULL

All	NULL
Rights	NULL
Reserved	NULL
.	NULL

Role	NULL
of	NULL
Cellular	NULL
Tumor	NULL
Necrosis	NULL
Factor	NULL
Receptor-Associated	NULL
Factors	NULL
in	NULL
NF-	NULL
«	NULL
B	NULL
Activation	NULL
and	NULL
Lymphocyte	NULL
Transformation	NULL
by	NULL
Herpesvirus	NULL
Saimiri	NULL
STP	NULL
HEUIRAN	NULL
LEE	NULL
,	NULL
*	NULL
``	NULL
JOONG-KOOK	NULL
CHOI	NULL
,	NULL
MENGTAO	NULL
LI	NULL
,	NULL
KEN	NULL
KAYE	NULL
,	NULL
``	NULL
ELLIOTT	NULL
KIEFF	NULL
,	NULL
``	NULL
anp	NULL
JAE	NULL
U	NULL
.	NULL

Department	NULL
of	NULL
Microbiology	NULL
and	NULL
Molecular	NULL
Genetics	NULL
,	NULL
New	NULL
England	NULL
Regional	NULL
Primate	NULL
Research	NULL
Center	NULL
,	NULL
Harvard	NULL
Medical	NULL
School	NULL
,	NULL
Southborough	NULL
,	NULL
Massachusetts	NULL
01772-9102	NULL
``	NULL
;	NULL
Brigham	NULL
and	NULL
Women	NULL
's	NULL
Hospital	NULL
,	NULL
Harvard	NULL
Medical	NULL
School	NULL
,	NULL
Boston	NULL
,	NULL
Massachusetts	NULL
02115	NULL
;	NULL
and	NULL
Yonsei	NULL
Cancer	NULL
Center	NULL
,	NULL
Institute	NULL
of	NULL
Cancer	NULL
Research	NULL
,	NULL
Yonsei	NULL
University	NULL
College	NULL
of	NULL
Medicine	NULL
,	NULL
134	NULL
Sinchon-Dong	NULL
,	NULL
Seoul	NULL
,	NULL
Korea®	NULL
Received	NULL
1	NULL
December	NULL
1998/Accepted	NULL
15	NULL
February	NULL
1999	NULL
The	NULL
STP	NULL
oncoproteins	NULL
of	NULL
the	NULL
herpesvirus	NULL
saimiri	NULL
(	NULL
HVS	NULL
)	NULL
subgroup	NULL
A	NULL
strain	NULL
11	NULL
and	NULL
subgroup	NULL
C	NULL
strain	NULL
488	NULL
are	NULL
now	NULL
found	NULL
to	NULL
be	NULL
stably	NULL
associated	NULL
with	NULL
tumor	NULL
necrosis	NULL
factor	NULL
receptor-associated	NULL
factor	NULL
(	NULL
TRAF	NULL
)	NULL
1	NULL
,	NULL
2	NULL
,	NULL
or	NULL
3	NULL
.	NULL

Mutational	NULL
analyses	NULL
identified	NULL
residues	NULL
of	NULL
PXQXT/S	NULL
in	NULL
STP-A11	NULL
as	NULL
critical	NULL
for	NULL
TRAF	NULL
association	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
a	NULL
somewhat	NULL
divergent	NULL
region	NULL
of	NULL
STP-C488	NULL
is	NULL
critical	NULL
for	NULL
TRAF	NULL
association	NULL
.	NULL

Mutational	NULL
analysis	NULL
also	NULL
revealed	NULL
that	NULL
STP-C488	NULL
induced	NULL
NF-KB	NULL
activation	NULL
that	NULL
was	NULL
correlated	NULL
with	NULL
its	NULL
ability	NULL
to	NULL
associate	NULL
with	NULL
TRAFs	NULL
.	NULL

The	NULL
HVS	NULL
STP-C488	NULL
P	NULL
,	NULL
,	NULL
-R	NULL
mutant	NULL
was	NULL
deficient	NULL
in	NULL
human	NULL
T-lymphocyte	NULL
transformation	NULL
to	NULL
interleukin-2-independent	NULL
growth	NULL
but	NULL
showed	NULL
wild-type	NULL
phenotype	NULL
for	NULL
marmoset	NULL
T-lymphocyte	NULL
transformation	NULL
in	NULL
vitro	NULL
and	NULL
in	NULL
vivo	NULL
.	NULL

The	NULL
STP-C488	NULL
P	NULL
;	NULL
,	NULL
-R	NULL
mutant	NULL
was	NULL
also	NULL
defective	NULL
in	NULL
Rat-1	NULL
fibroblast	NULL
transformation	NULL
,	NULL
and	NULL
fibroblast	NULL
cell	NULL
transformation	NULL
was	NULL
blocked	NULL
by	NULL
a	NULL
TRAF2	NULL
dominant-negative	NULL
mutant	NULL
.	NULL

These	NULL
data	NULL
implicate	NULL
TRAFs	NULL
in	NULL
STP-C488-mediated	NULL
transformation	NULL
of	NULL
human	NULL
lymphocytes	NULL
and	NULL
rodent	NULL
fibroblasts	NULL
.	NULL

Other	NULL
factors	NULL
are	NULL
implicated	NULL
in	NULL
immortalization	NULL
of	NULL
common	NULL
marmoset	NULL
T	NULL
lymphocytes	NULL
and	NULL
may	NULL
also	NULL
be	NULL
critical	NULL
in	NULL
the	NULL
transformation	NULL
of	NULL
human	NULL
lymphocytes	NULL
and	NULL
rodent	NULL
fibroblasts	NULL
.	NULL

Members	NULL
of	NULL
the	NULL
tumor	NULL
necrosis	NULL
factor	NULL
(	NULL
TNF	NULL
)	NULL
receptor	NULL
(	NULL
TNFR	NULL
)	NULL
superfamily	NULL
are	NULL
important	NULL
for	NULL
lymphoid	NULL
organ	NULL
devel-opment	NULL
,	NULL
lymphocyte	NULL
activation	NULL
,	NULL
acute-phase	NULL
responses	NULL
,	NULL
cell	NULL
growth	NULL
,	NULL
and	NULL
apoptosis	NULL
(	NULL
3	NULL
,	NULL
22	NULL
,	NULL
49	NULL
)	NULL
.	NULL

The	NULL
TNFR	NULL
superfamily	NULL
includes	NULL
TNFR1	NULL
,	NULL
TNFR2	NULL
,	NULL
CD27	NULL
,	NULL
CD30	NULL
,	NULL
CD40	NULL
,	NULL
Fas	NULL
(	NULL
CD95	NULL
)	NULL
,	NULL
4-1BB	NULL
,	NULL
and	NULL
OX40	NULL
(	NULL
45	NULL
)	NULL
.	NULL

The	NULL
cytoplasmic	NULL
regions	NULL
of	NULL
TNFR1	NULL
,	NULL
TNFR2	NULL
,	NULL
CD30	NULL
,	NULL
or	NULL
CD40	NULL
are	NULL
required	NULL
for	NULL
receptor-mediated	NULL
signaling	NULL
and	NULL
interact	NULL
with	NULL
TNF	NULL
receptor-associated	NULL
factors	NULL
(	NULL
TRAFs	NULL
)	NULL
(	NULL
8	NULL
,	NULL
23	NULL
,	NULL
43	NULL
,	NULL
48	NULL
)	NULL
.	NULL

TRAFZ	NULL
and	NULL
TRAF3	NULL
have	NULL
an	NULL
amino	NULL
terminal	NULL
RING	NULL
finger	NULL
structure	NULL
,	NULL
and	NULL
all	NULL
TRAFs	NULL
have	NULL
more	NULL
than	NULL
one	NULL
zinc	NULL
finger	NULL
.	NULL

TRAFs	NULL
also	NULL
have	NULL
a	NULL
predicted	NULL
extended	NULL
alpha-helical	NULL
coiled-coiled	NULL
hydrophobic	NULL
heptad	NULL
repeat	NULL
domain	NULL
(	NULL
8	NULL
)	NULL
.	NULL

A	NULL
carboxyl-terminal	NULL
TRAF	NULL
domain	NULL
of	NULL
approximately	NULL
200	NULL
amino	NULL
acids	NULL
can	NULL
be	NULL
further	NULL
divided	NULL
into	NULL
the	NULL
TRAF-N	NULL
and	NULL
TRAF-C	NULL
subdomains	NULL
.	NULL

The	NULL
highly	NULL
conserved	NULL
carboxyl-terminal	NULL
TRAF-C	NULL
domain	NULL
mediates	NULL
interaction	NULL
with	NULL
TNFRs	NULL
(	NULL
48	NULL
)	NULL
.	NULL

The	NULL
cytoplasmic	NULL
region	NULL
of	NULL
LMP1	NULL
,	NULL
which	NULL
is	NULL
a	NULL
key	NULL
effector	NULL
of	NULL
Epstein-Barr	NULL
virus	NULL
(	NULL
EBV	NULL
)	NULL
-mediated	NULL
transformation	NULL
,	NULL
also	NULL
binds	NULL
to	NULL
TRAFs	NULL
,	NULL
and	NULL
this	NULL
interaction	NULL
is	NULL
essential	NULL
for	NULL
B	NULL
lymphocyte	NULL
growth	NULL
transformation	NULL
(	NULL
24	NULL
,	NULL
38	NULL
)	NULL
.	NULL

Human	NULL
and	NULL
simian	NULL
LMP1	NULL
,	NULL
CD40	NULL
,	NULL
and	NULL
CD30	NULL
and	NULL
a	NULL
cytoplasmic	NULL
TRAF-interacting	NULL
protein	NULL
,	NULL
TANK	NULL
,	NULL
share	NULL
a	NULL
PXQXT/S	NULL
core	NULL
sequence	NULL
through	NULL
which	NULL
they	NULL
interact	NULL
with	NULL
TRAFs	NULL
(	NULL
8	NULL
,	NULL
20	NULL
,	NULL
21	NULL
)	NULL
.	NULL

TRAF2	NULL
is	NULL
a	NULL
mediator	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
Jun	NULL
kinase	NULL
activation	NULL
from	NULL
the	NULL
TNFRs	NULL
and	NULL
LMP1	NULL
(	NULL
13	NULL
,	NULL
35	NULL
,	NULL
46	NULL
,	NULL
54	NULL
)	NULL
.	NULL

Herpesvirus	NULL
saimiri	NULL
(	NULL
HVS	NULL
)	NULL
,	NULL
a	NULL
gamma-2	NULL
herpesvirus	NULL
or	NULL
rhadi-novirus	NULL
,	NULL
infects	NULL
most	NULL
squirrel	NULL
monkeys	NULL
without	NULL
causing	NULL
apparent	NULL
disease	NULL
(	NULL
11	NULL
,	NULL
17	NULL
)	NULL
.	NULL

In	NULL
other	NULL
nonhuman	NULL
primates	NULL
,	NULL
however	NULL
,	NULL
*	NULL
Corresponding	NULL
author	NULL
.	NULL

Mailing	NULL
address	NULL
:	NULL
New	NULL
England	NULL
Regional	NULL
Primate	NULL
Research	NULL
Center	NULL
,	NULL
Harvard	NULL
Medical	NULL
School	NULL
,	NULL
1	NULL
Pine	NULL
Hill	NULL
Dr.	NULL
,	NULL
P.O	NULL
.	NULL

Box	NULL
9102	NULL
,	NULL
Southborough	NULL
,	NULL
MA	NULL
01772	NULL
.	NULL

Phone	NULL
:	NULL
(	NULL
508	NULL
)	NULL
624-8083	NULL
.	NULL

Fax	NULL
:	NULL
(	NULL
508	NULL
)	NULL
624-8190	NULL
.	NULL

E-mail	NULL
:	NULL
jae_jung	NULL
@	NULL
hms.harvard.edu	NULL
.	NULL

3913	NULL
HVS	NULL
induces	NULL
rapidly	NULL
fatal	NULL
T-cell	NULL
lymphoproliferative	NULL
diseases	NULL
(	NULL
19	NULL
,	NULL
27	NULL
)	NULL
.	NULL

Sequence	NULL
divergence	NULL
among	NULL
HVS	NULL
isolates	NULL
is	NULL
most	NULL
extensive	NULL
at	NULL
the	NULL
left	NULL
end	NULL
of	NULL
the	NULL
viral	NULL
genomic	NULL
DNA	NULL
and	NULL
is	NULL
the	NULL
basis	NULL
for	NULL
the	NULL
classification	NULL
of	NULL
HVS	NULL
into	NULL
subgroups	NULL
A	NULL
,	NULL
B	NULL
,	NULL
and	NULL
C	NULL
(	NULL
9	NULL
,	NULL
36	NULL
)	NULL
.	NULL

Sequence	NULL
variation	NULL
in	NULL
the	NULL
STP	NULL
gene	NULL
in	NULL
this	NULL
region	NULL
correlates	NULL
with	NULL
different	NULL
capacities	NULL
for	NULL
immortalizing	NULL
T	NULL
lymphocytes	NULL
in	NULL
vitro	NULL
and	NULL
for	NULL
inducing	NULL
lymphoma	NULL
in	NULL
nonhuman	NULL
primates	NULL
(	NULL
5	NULL
,	NULL
9	NULL
,	NULL
12	NULL
,	NULL
32	NULL
)	NULL
.	NULL

Subgroup	NULL
A	NULL
and	NULL
subgroup	NULL
C	NULL
viruses	NULL
can	NULL
immortalize	NULL
common	NULL
marmoset	NULL
T	NULL
lymphocytes	NULL
to	NULL
interleu-kin-2	NULL
(	NULL
IL-2	NULL
)	NULL
-independent	NULL
proliferation	NULL
(	NULL
12	NULL
,	NULL
47	NULL
)	NULL
.	NULL

Highly	NULL
oncogenic	NULL
subgroup	NULL
C	NULL
strains	NULL
are	NULL
also	NULL
able	NULL
to	NULL
immortalize	NULL
human	NULL
,	NULL
rabbit	NULL
,	NULL
and	NULL
rhesus	NULL
monkey	NULL
lymphocytes	NULL
and	NULL
induce	NULL
fulminant	NULL
lymphoma	NULL
in	NULL
rhesus	NULL
monkeys	NULL
(	NULL
2	NULL
,	NULL
4	NULL
,	NULL
6	NULL
,	NULL
37	NULL
)	NULL
.	NULL

The	NULL
STPs	NULL
of	NULL
subgroup	NULL
A	NULL
or	NULL
C	NULL
strains	NULL
(	NULL
STP-A	NULL
or	NULL
STP-C	NULL
)	NULL
can	NULL
transform	NULL
rodent	NULL
fibroblast	NULL
cells	NULL
in	NULL
vitro	NULL
.	NULL

STP-C	NULL
is	NULL
considerably	NULL
more	NULL
potent	NULL
(	NULL
28	NULL
,	NULL
30	NULL
)	NULL
.	NULL

STP-C488	NULL
associates	NULL
with	NULL
cellular	NULL
Ras	NULL
in	NULL
transformed	NULL
cells	NULL
(	NULL
25	NULL
)	NULL
.	NULL

Mutations	NULL
that	NULL
disrupt	NULL
Ras	NULL
association	NULL
disrupt	NULL
the	NULL
transforming	NULL
ability	NULL
of	NULL
the	NULL
STP-C488	NULL
oncogene	NULL
(	NULL
25	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
STP-A	NULL
binds	NULL
to	NULL
the	NULL
SH2	NULL
domain	NULL
of	NULL
Src	NULL
kinase	NULL
and	NULL
is	NULL
phosphorylated	NULL
by	NULL
the	NULL
associated	NULL
Src	NULL
kinase	NULL
(	NULL
34	NULL
)	NULL
.	NULL

Transgenic	NULL
mice	NULL
expressing	NULL
STP-C488	NULL
developed	NULL
invasive	NULL
epithelial	NULL
cell	NULL
tumors	NULL
(	NULL
39	NULL
)	NULL
,	NULL
while	NULL
STP-A11	NULL
transgenic	NULL
mice	NULL
developed	NULL
peripheral	NULL
pleomorphic	NULL
T-cell	NULL
lymphomas	NULL
(	NULL
33	NULL
)	NULL
.	NULL

Deletion	NULL
of	NULL
STP	NULL
from	NULL
the	NULL
group	NULL
C	NULL
strain	NULL
488	NULL
or	NULL
from	NULL
the	NULL
group	NULL
A	NULL
strain	NULL
11	NULL
yields	NULL
viruses	NULL
that	NULL
are	NULL
no	NULL
longer	NULL
capable	NULL
of	NULL
immortalizing	NULL
lymphocytes	NULL
in	NULL
vitro	NULL
or	NULL
of	NULL
inducing	NULL
fatal	NULL
lymphomas	NULL
in	NULL
common	NULL
marmosets	NULL
(	NULL
9	NULL
,	NULL
10	NULL
,	NULL
12	NULL
,	NULL
14	NULL
,	NULL
32	NULL
,	NULL
40	NULL
)	NULL
.	NULL

Since	NULL
HVS	NULL
lacking	NULL
STP	NULL
can	NULL
be	NULL
repeatedly	NULL
isolated	NULL
from	NULL
the	NULL
peripheral	NULL
blood	NULL
of	NULL
common	NULL
marmosets	NULL
for	NULL
months	NULL
or	NULL
years	NULL
,	NULL
STP	NULL
is	NULL
not	NULL
required	NULL
for	NULL
viral	NULL
replication	NULL
or	NULL
persistence	NULL
in	NULL
vivo	NULL
,	NULL
but	NULL
it	NULL
is	NULL
essential	NULL
for	NULL
transformation	NULL
in	NULL
cell	NULL
culture	NULL
and	NULL
for	NULL
lymphoma	NULL
induction	NULL
in	NULL
common	NULL
marmosets	NULL
(	NULL
9	NULL
,	NULL
14	NULL
)	NULL
.	NULL

STP-A11	NULL
and	NULL
STP-C488	NULL
are	NULL
similar	NULL
in	NULL
genome	NULL
location	NULL
and	NULL
3914	NULL
LEE	NULL
ET	NULL
AL	NULL
.	NULL

orientation	NULL
and	NULL
have	NULL
limited	NULL
sequence	NULL
similarity	NULL
(	NULL
5	NULL
,	NULL
28	NULL
)	NULL
.	NULL

Both	NULL
open	NULL
reading	NULL
frames	NULL
encode	NULL
a	NULL
highly	NULL
acidic	NULL
amino	NULL
terminus	NULL
.	NULL

STP-C488	NULL
has	NULL
18	NULL
direct	NULL
repeats	NULL
of	NULL
a	NULL
collagen-like	NULL
motif	NULL
(	NULL
Gly-Pro-Pro	NULL
or	NULL
Gly-Pro-GIn	NULL
)	NULL
that	NULL
comprises	NULL
more	NULL
than	NULL
50	NULL
%	NULL
of	NULL
the	NULL
protein	NULL
and	NULL
is	NULL
predicted	NULL
to	NULL
have	NULL
an	NULL
alpha-helical	NULL
triple	NULL
structure	NULL
(	NULL
5	NULL
)	NULL
.	NULL

A	NULL
mutation	NULL
which	NULL
disrupts	NULL
the	NULL
collagen	NULL
repeats	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
disrupt	NULL
the	NULL
transforming	NULL
activity	NULL
of	NULL
STP-C488	NULL
(	NULL
26	NULL
)	NULL
.	NULL

STP-A11	NULL
is	NULL
also	NULL
glycine	NULL
and	NULL
proline	NULL
rich	NULL
.	NULL

STP-A11	NULL
and	NULL
STP-C488	NULL
proteins	NULL
have	NULL
highly	NULL
hydrophobic	NULL
carboxyl	NULL
termini	NULL
which	NULL
are	NULL
sufficient	NULL
for	NULL
membrane	NULL
interaction	NULL
(	NULL
26	NULL
)	NULL
.	NULL

Since	NULL
STP-C	NULL
likely	NULL
oligomerizes	NULL
through	NULL
its	NULL
collagen-like	NULL
motif	NULL
and	NULL
associates	NULL
with	NULL
cellular	NULL
membranes	NULL
,	NULL
STP-C	NULL
may	NULL
mimic	NULL
a	NULL
ligand-independent	NULL
constitutively	NULL
active	NULL
receptor	NULL
,	NULL
like	NULL
the	NULL
EBV	NULL
LMP1	NULL
protein	NULL
.	NULL

STP-A	NULL
could	NULL
have	NULL
similar	NULL
properties	NULL
.	NULL

In	NULL
this	NULL
report	NULL
,	NULL
we	NULL
investigate	NULL
this	NULL
hypothesis	NULL
and	NULL
find	NULL
that	NULL
STP-A	NULL
and	NULL
STP-C	NULL
associate	NULL
with	NULL
TRAF	NULL
1	NULL
,	NULL
2	NULL
,	NULL
or	NULL
3	NULL
.	NULL

Furthermore	NULL
,	NULL
the	NULL
STP-C488	NULL
TRAF	NULL
binding	NULL
site	NULL
is	NULL
required	NULL
for	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
and	NULL
cell	NULL
growth	NULL
transformation	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Cell	NULL
culture	NULL
and	NULL
virus	NULL
propagation	NULL
.	NULL

Rat-1	NULL
,	NULL
COS-1	NULL
,	NULL
BOSC23	NULL
,	NULL
and	NULL
owl	NULL
monkey	NULL
kidney	NULL
(	NULL
OMK	NULL
1637	NULL
)	NULL
cells	NULL
cultivated	NULL
in	NULL
Dulbecco	NULL
's	NULL
modified	NULL
Eagle	NULL
's	NULL
medium	NULL
or	NULL
minimal	NULL
essential	NULL
medium	NULL
supplemented	NULL
with	NULL
penicillin	NULL
,	NULL
streptomycin	NULL
,	NULL
1-glu-tamine	NULL
,	NULL
and	NULL
10	NULL
%	NULL
(	NULL
vol/vol	NULL
)	NULL
heat-inactivated	NULL
fetal	NULL
bovine	NULL
serum	NULL
(	NULL
GIBCO	NULL
BRL	NULL
,	NULL
Grand	NULL
Island	NULL
,	NULL
N.Y.	NULL
)	NULL
were	NULL
used	NULL
for	NULL
the	NULL
propagation	NULL
of	NULL
the	NULL
HVS	NULL
strain	NULL
C488	NULL
.	NULL

Low-passage-number	NULL
OMK	NULL
cells	NULL
(	NULL
<	NULL
30	NULL
passages	NULL
)	NULL
were	NULL
used	NULL
for	NULL
the	NULL
transfections	NULL
.	NULL

Primary	NULL
human	NULL
and	NULL
common	NULL
marmoset	NULL
(	NULL
CeHlithrix	NULL
jacchus	NULL
)	NULL
peripheral	NULL
blood	NULL
mononuclear	NULL
cells	NULL
(	NULL
PBMCs	NULL
)	NULL
were	NULL
purified	NULL
by	NULL
using	NULL
lymphocyte	NULL
separation	NULL
medium	NULL
(	NULL
Organon	NULL
Teknika	NULL
Corp.	NULL
,	NULL
Malvern	NULL
,	NULL
Pa.	NULL
)	NULL
.	NULL

Cultures	NULL
of	NULL
human	NULL
and	NULL
common	NULL
marmoset	NULL
PBMCs	NULL
in	NULL
immortalization	NULL
assays	NULL
with	NULL
HVS	NULL
recombinants	NULL
were	NULL
performed	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
supplemented	NULL
with	NULL
penicillin	NULL
,	NULL
streptomycin	NULL
,	NULL
Fun-gizone	NULL
,	NULL
L-glutamine	NULL
,	NULL
20	NULL
%	NULL
(	NULL
vol/vol	NULL
)	NULL
heat-inactivated	NULL
fetal	NULL
bovine	NULL
serum	NULL
,	NULL
and	NULL
5	NULL
mg	NULL
of	NULL
B-mercaptocthanol	NULL
per	NULL
liter	NULL
.	NULL

A	NULL
DEAE	NULL
or	NULL
calcium	NULL
phosphate	NULL
transfection	NULL
was	NULL
used	NULL
for	NULL
transient	NULL
expression	NULL
in	NULL
COS-1	NULL
or	NULL
BOSC23	NULL
cells	NULL
,	NULL
respectively	NULL
.	NULL

Rat-1	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
plasmid	NULL
peDNA3-TRAF2	NULL
A6-86	NULL
by	NULL
the	NULL
calcium	NULL
phosphate	NULL
protocol	NULL
,	NULL
followed	NULL
by	NULL
the	NULL
selection	NULL
with	NULL
500	NULL
ug	NULL
of	NULL
G418	NULL
per	NULL
ml	NULL
.	NULL

Subsequently	NULL
,	NULL
these	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
pBabe-puro	NULL
or	NULL
pBabe-STP-C488	NULL
and	NULL
selected	NULL
with	NULL
5	NULL
ug	NULL
of	NULL
puromycin/ml	NULL
.	NULL

Plasmid	NULL
constructions	NULL
.	NULL

All	NULL
STP-C488	NULL
mutants	NULL
have	NULL
been	NULL
described	NULL
previously	NULL
(	NULL
26	NULL
)	NULL
.	NULL

Mutations	NULL
in	NULL
STP-A1l	NULL
were	NULL
generated	NULL
by	NULL
PCR	NULL
by	NULL
using	NULL
oligonucleotide-directed	NULL
mutagenesis	NULL
(	NULL
16	NULL
)	NULL
.	NULL

Oligonucleotide	NULL
mutant	NULL
primers	NULL
from	NULL
complementary	NULL
strands	NULL
of	NULL
STP-A11	NULL
were	NULL
synthesized	NULL
with	NULL
specific	NULL
restriction	NULL
enzyme	NULL
sites	NULL
within	NULL
5	NULL
'	NULL
and	NULL
3	NULL
'	NULL
primers	NULL
to	NULL
facilitate	NULL
cloning	NULL
into	NULL
pBluescript	NULL
KS	NULL
(	NULL
+	NULL
)	NULL
(	NULL
Stratagene	NULL
,	NULL
San	NULL
Diego	NULL
,	NULL
Calif.	NULL
)	NULL
.	NULL

PCR	NULL
was	NULL
carried	NULL
out	NULL
with	NULL
a	NULL
DNA	NULL
thermal	NULL
cycler	NULL
(	NULL
Perkin-Elmer	NULL
Cetus	NULL
Instruments	NULL
,	NULL
Norwalk	NULL
,	NULL
Conn.	NULL
)	NULL
under	NULL
the	NULL
following	NULL
conditions	NULL
:	NULL
30	NULL
cycles	NULL
of	NULL
1	NULL
min	NULL
at	NULL
55°C	NULL
for	NULL
annealing	NULL
,	NULL
4	NULL
min	NULL
at	NULL
72°C	NULL
for	NULL
polymerization	NULL
,	NULL
and	NULL
1	NULL
min	NULL
at	NULL
94°C	NULL
for	NULL
denaturation	NULL
.	NULL

The	NULL
amplified	NULL
DNA	NULL
fragments	NULL
containing	NULL
mutations	NULL
in	NULL
STP-A11	NULL
were	NULL
purified	NULL
and	NULL
cloned	NULL
into	NULL
the	NULL
pBluescript	NULL
KS	NULL
(	NULL
+	NULL
)	NULL
vector	NULL
.	NULL

Each	NULL
STP-A11	NULL
mutant	NULL
was	NULL
completely	NULL
sequenced	NULL
to	NULL
verify	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
mutation	NULL
and	NULL
the	NULL
absence	NULL
of	NULL
any	NULL
other	NULL
changes	NULL
.	NULL

After	NULL
confirmation	NULL
of	NULL
the	NULL
DNA	NULL
sequence	NULL
,	NULL
DNA	NULL
containing	NULL
the	NULL
desired	NULL
STP-A1l	NULL
mutation	NULL
was	NULL
recloned	NULL
into	NULL
EcoRI	NULL
and	NULL
Bg/II	NULL
cloning	NULL
sites	NULL
of	NULL
the	NULL
pFJ	NULL
vector	NULL
for	NULL
gene	NULL
expression	NULL
.	NULL

TRAF2	NULL
A6-86	NULL
and	NULL
flag-tagged	NULL
TRAF1	NULL
,	NULL
TRAF2	NULL
and	NULL
TRAF3	NULL
have	NULL
been	NULL
described	NULL
previously	NULL
(	NULL
31	NULL
)	NULL
.	NULL

Flag-tagged	NULL
TRAF3-C	NULL
and	NULL
TRAF3	NULL
AC	NULL
were	NULL
constructed	NULL
by	NULL
PCR	NULL
by	NULL
using	NULL
oligonucleotide-directed	NULL
mutagenesis	NULL
and	NULL
completely	NULL
sequenced	NULL
to	NULL
verify	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
mutation	NULL
and	NULL
the	NULL
absence	NULL
of	NULL
any	NULL
other	NULL
changes	NULL
.	NULL

Virion	NULL
DNA	NULL
isolation	NULL
.	NULL

HVS	NULL
virion	NULL
preparations	NULL
were	NULL
obtained	NULL
from	NULL
the	NULL
virus-containing	NULL
medium	NULL
by	NULL
removal	NULL
of	NULL
OMK	NULL
cell	NULL
debris	NULL
by	NULL
low-speed	NULL
centrifugation	NULL
,	NULL
followed	NULL
by	NULL
pelleting	NULL
of	NULL
the	NULL
virus	NULL
at	NULL
18,000	NULL
rpm	NULL
for	NULL
2	NULL
h	NULL
in	NULL
an	NULL
S§-34	NULL
rotor	NULL
.	NULL

To	NULL
purify	NULL
intact	NULL
virion	NULL
DNA	NULL
,	NULL
the	NULL
virus	NULL
was	NULL
disrupted	NULL
at	NULL
60°C	NULL
for	NULL
2	NULL
h	NULL
in	NULL
lysis	NULL
buffer	NULL
containing	NULL
10	NULL
mM	NULL
Tris	NULL
(	NULL
pH	NULL
8.5	NULL
)	NULL
,	NULL
1	NULL
mM	NULL
EDTA	NULL
,	NULL
1	NULL
%	NULL
(	NULL
vol/vol	NULL
)	NULL
Sarkosyl	NULL
,	NULL
and	NULL
0.1	NULL
mg	NULL
of	NULL
proteinase	NULL
K/ml	NULL
.	NULL

Extraction	NULL
of	NULL
the	NULL
aqueous	NULL
solution	NULL
,	NULL
first	NULL
with	NULL
an	NULL
equal	NULL
volume	NULL
of	NULL
phenol	NULL
and	NULL
then	NULL
twice	NULL
with	NULL
chloroform	NULL
,	NULL
was	NULL
sufficient	NULL
to	NULL
purify	NULL
the	NULL
virion	NULL
DNA	NULL
for	NULL
use	NULL
in	NULL
transfections	NULL
.	NULL

Sterile	NULL
cut	NULL
pipette	NULL
tips	NULL
were	NULL
used	NULL
for	NULL
manipulating	NULL
virion	NULL
DNA	NULL
without	NULL
shearing	NULL
.	NULL

Construction	NULL
of	NULL
recombinant	NULL
HVS	NULL
.	NULL

Generation	NULL
of	NULL
the	NULL
P	NULL
;	NULL
-	NULL
>	NULL
R	NULL
mutation	NULL
in	NULL
STP-C488	NULL
by	NULL
oligonucleotide-directed	NULL
mutagenesis	NULL
has	NULL
been	NULL
described	NULL
previously	NULL
(	NULL
26	NULL
)	NULL
.	NULL

A	NULL
3.6-kb	NULL
clone	NULL
,	NULL
pNEB-C488-PX	NULL
,	NULL
containing	NULL
the	NULL
tyrosine	NULL
kinase-interacting	NULL
protein	NULL
tip	NULL
,	NULL
STP-C488	NULL
,	NULL
and	NULL
herpesvirus	NULL
saimiri	NULL
U	NULL
RNAs	NULL
(	NULL
HSURs	NULL
)	NULL
(	NULL
5	NULL
,	NULL
15	NULL
)	NULL
,	NULL
was	NULL
used	NULL
to	NULL
provide	NULL
a	NULL
subcloning	NULL
vector	NULL
with	NULL
flanking	NULL
sequence	NULL
adequate	NULL
to	NULL
facilitate	NULL
recombination	NULL
during	NULL
cotransfection	NULL
.	NULL

Digestion	NULL
of	NULL
this	NULL
vector	NULL
with	NULL
EcoRV	NULL
and	NULL
Spel	NULL
permitted	NULL
insertion	NULL
of	NULL
the	NULL
corresponding	NULL
STP	NULL
fragment	NULL
containing	NULL
the	NULL
P	NULL
;	NULL
,	NULL
-	NULL
>	NULL
R	NULL
mutation	NULL
.	NULL

Linearized	NULL
plasmid	NULL
DNA	NULL
containing	NULL
the	NULL
3.6-kb	NULL
viral	NULL
DNA	NULL
with	NULL
the	NULL
STP-C488/	NULL
P	NULL
:	NULL
,	NULL
-R	NULL
mutation	NULL
was	NULL
cotransfected	NULL
into	NULL
OMK	NULL
cells	NULL
with	NULL
HVSASTP/SV40-SEAP	NULL
virion	NULL
DNA	NULL
by	NULL
the	NULL
calcium	NULL
phosphate	NULL
protocol	NULL
.	NULL

A	NULL
pure	NULL
form	NULL
of	NULL
recombinant	NULL
virus	NULL
with	NULL
the	NULL
secreted	NULL
engineered	NULL
alkaline	NULL
phosphatase	NULL
(	NULL
SEAP	NULL
)	NULL
reporter	NULL
re	NULL
J.	NULL
Virou	NULL
.	NULL

placed	NULL
with	NULL
was	NULL
isolated	NULL
by	NULL
limiting	NULL
dilution	NULL
and	NULL
repeated	NULL
selection	NULL
of	NULL
SEAP-negative	NULL
virus	NULL
onto	NULL
OMK	NULL
cell	NULL
monolayers	NULL
in	NULL
48-well	NULL
tissue	NULL
culture	NULL
plates	NULL
performed	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
15	NULL
)	NULL
.	NULL

SEAP	NULL
production	NULL
was	NULL
detected	NULL
by	NULL
a	NULL
liquid	NULL
scintillation	NULL
counter	NULL
;	NULL
the	NULL
chemiluminescence	NULL
produced	NULL
in	NULL
cell	NULL
culture	NULL
medium	NULL
was	NULL
assayed	NULL
by	NULL
using	NULL
Phospha-Light	NULL
reagents	NULL
(	NULL
Tropix	NULL
Inc.	NULL
,	NULL
Bedford	NULL
,	NULL
Mass	NULL
.	NULL
)	NULL

according	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
recommendations	NULL
.	NULL

In	NULL
vitro	NULL
i	NULL
talization	NULL
of	NULL
h	NULL
and	NULL
marmoset	NULL
lymphocytes	NULL
.	NULL

Assays	NULL
of	NULL
lymphocyte	NULL
immortalization	NULL
in	NULL
vitro	NULL
have	NULL
been	NULL
described	NULL
previously	NULL
(	NULL
14	NULL
)	NULL
.	NULL

PBMCs	NULL
were	NULL
isolated	NULL
from	NULL
heparinized	NULL
blood	NULL
specimens	NULL
from	NULL
human	NULL
donors	NULL
and	NULL
common	NULL
marmosets	NULL
(	NULL
C.	NULL
jfecchus	NULL
)	NULL
by	NULL
centrifugation	NULL
through	NULL
lymphocyte	NULL
separation	NULL
medium	NULL
(	NULL
Organon	NULL
Teknika	NULL
Corp.	NULL
)	NULL
followed	NULL
by	NULL
washing	NULL
in	NULL
RPMI	NULL
culture	NULL
medium	NULL
.	NULL

PBMCs	NULL
from	NULL
each	NULL
donor	NULL
were	NULL
individually	NULL
washed	NULL
,	NULL
resus-pended	NULL
in	NULL
RPMI	NULL
,	NULL
and	NULL
then	NULL
distributed	NULL
in	NULL
1-ml	NULL
volumes	NULL
containing	NULL
approximately	NULL
10°	NULL
cells	NULL
into	NULL
12-well	NULL
tissue	NULL
culture	NULL
plates	NULL
.	NULL

A	NULL
single	NULL
well	NULL
containing	NULL
PBMCs	NULL
from	NULL
each	NULL
donor	NULL
was	NULL
then	NULL
infected	NULL
at	NULL
a	NULL
multiplicity	NULL
of	NULL
infection	NULL
ranging	NULL
from	NULL
1	NULL
to	NULL
5	NULL
with	NULL
1	NULL
ml	NULL
of	NULL
fresh	NULL
,	NULL
purified	NULL
HVS	NULL
viral	NULL
stocks	NULL
.	NULL

Cells	NULL
were	NULL
maintained	NULL
with	NULL
RPMI	NULL
1640	NULL
growth	NULL
medium	NULL
which	NULL
was	NULL
changed	NULL
every	NULL
3	NULL
to	NULL
4	NULL
days	NULL
.	NULL

Immortalization	NULL
or	NULL
cell	NULL
death	NULL
was	NULL
assessed	NULL
microscopically	NULL
.	NULL

Experimental	NULL
infection	NULL
of	NULL
common	NULL
marmosets	NULL
.	NULL

The	NULL
in	NULL
vivo	NULL
oncogenicity	NULL
of	NULL
the	NULL
HVS-C488	NULL
recombinants	NULL
was	NULL
assessed	NULL
by	NULL
experimental	NULL
infection	NULL
of	NULL
common	NULL
marmosets	NULL
.	NULL

Marmosets	NULL
were	NULL
injected	NULL
intramuscularly	NULL
with	NULL
10°	NULL
50	NULL
%	NULL
tissue	NULL
culture	NULL
infective	NULL
doses	NULL
of	NULL
virus	NULL
in	NULL
a	NULL
volume	NULL
of	NULL
1	NULL
ml	NULL
.	NULL

Sera	NULL
and	NULL
blood	NULL
cell	NULL
pellets	NULL
were	NULL
collected	NULL
and	NULL
frozen	NULL
at	NULL
-70°C	NULL
weekly	NULL
during	NULL
the	NULL
first	NULL
4	NULL
weeks	NULL
and	NULL
every	NULL
2	NULL
weeks	NULL
thereafter	NULL
.	NULL

Viral	NULL
loads	NULL
in	NULL
PBMC	NULL
specimens	NULL
were	NULL
assessed	NULL
periodically	NULL
by	NULL
duplicate	NULL
plating	NULL
of	NULL
10°	NULL
PBMCs	NULL
and	NULL
serial	NULL
threefold	NULL
dilutions	NULL
of	NULL
PBMCs	NULL
on	NULL
OMK	NULL
cells	NULL
in	NULL
24-well	NULL
tissue	NULL
culture	NULL
plates	NULL
(	NULL
14	NULL
)	NULL
.	NULL

Animals	NULL
that	NULL
became	NULL
moribund	NULL
were	NULL
euthanized	NULL
and	NULL
received	NULL
complete	NULL
necropsies	NULL
.	NULL

Tissues	NULL
were	NULL
fixed	NULL
in	NULL
10	NULL
%	NULL
neutral	NULL
buffered	NULL
formalin	NULL
,	NULL
embedded	NULL
in	NULL
paraffin	NULL
,	NULL
sectioned	NULL
,	NULL
and	NULL
stained	NULL
with	NULL
hematoxylin	NULL
and	NULL
eosin	NULL
.	NULL

Immunoprecipitation	NULL
,	NULL
immunoblotting	NULL
,	NULL
and	NULL
antibodies	NULL
.	NULL

Cells	NULL
were	NULL
harvested	NULL
and	NULL
lysed	NULL
with	NULL
lysis	NULL
buffer	NULL
(	NULL
0.15	NULL
M	NULL
NaCl	NULL
,	NULL
0.5	NULL
%	NULL
Nonidet	NULL
P-40	NULL
,	NULL
and	NULL
50	NULL
mM	NULL
HEPES	NULL
buffer	NULL
[	NULL
pH	NULL
8.0	NULL
]	NULL
)	NULL
containing	NULL
1	NULL
mM	NULL
Na	NULL
;	NULL
VO	NULL
;	NULL
,	NULL
1	NULL
mM	NULL
NaF	NULL
,	NULL
and	NULL
protease	NULL
inhibitors	NULL
(	NULL
Ieupeptin	NULL
,	NULL
aprotinin	NULL
,	NULL
phenylmethylsulfonyl	NULL
fluoride	NULL
,	NULL
pepstatin	NULL
,	NULL
and	NULL
bestatin	NULL
)	NULL
.	NULL

Precleared	NULL
lysates	NULL
were	NULL
used	NULL
for	NULL
immunoprecipitation	NULL
or	NULL
immunoblot	NULL
analysis	NULL
.	NULL

The	NULL
rabbit	NULL
polyclonal	NULL
antibody	NULL
109	NULL
and	NULL
mouse	NULL
monoclonal	NULL
antibody	NULL
A1.4	NULL
directed	NULL
against	NULL
STP-C488	NULL
used	NULL
in	NULL
these	NULL
experiments	NULL
have	NULL
been	NULL
described	NULL
previously	NULL
(	NULL
28	NULL
)	NULL
.	NULL

Flag	NULL
and	NULL
AU-1	NULL
antibodies	NULL
were	NULL
purchased	NULL
from	NULL
KODAK	NULL
IBI	NULL
(	NULL
New	NULL
Haven	NULL
,	NULL
Conn.	NULL
)	NULL
and	NULL
BABCO	NULL
Biotech	NULL
(	NULL
Berkeley	NULL
,	NULL
Calif.	NULL
)	NULL
,	NULL
respectively	NULL
.	NULL

Isolation	NULL
of	NULL
genomic	NULL
DNA	NULL
and	NULL
PCR	NULL
analysis	NULL
.	NULL

Genomic	NULL
DNA	NULL
was	NULL
isolated	NULL
with	NULL
a	NULL
Qiagene	NULL
genomic	NULL
isolation	NULL
kit	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
protocol	NULL
.	NULL

Five	NULL
micrograms	NULL
of	NULL
purified	NULL
genomic	NULL
DNA	NULL
was	NULL
used	NULL
for	NULL
PCR	NULL
amplification	NULL
performed	NULL
by	NULL
using	NULL
a	NULL
5	NULL
'	NULL
primer	NULL
which	NULL
corresponds	NULL
to	NULL
the	NULL
upstream	NULL
sequence	NULL
of	NULL
the	NULL
STP-C488	NULL
gene	NULL
and	NULL
a	NULL
3	NULL
'	NULL
primer	NULL
which	NULL
corresponds	NULL
to	NULL
the	NULL
downstream	NULL
sequence	NULL
of	NULL
STP-C488	NULL
.	NULL

Amplified	NULL
DNA	NULL
was	NULL
cloned	NULL
into	NULL
the	NULL
TA	NULL
cloning	NULL
vector	NULL
(	NULL
Invitro-gen	NULL
,	NULL
San	NULL
Diego	NULL
,	NULL
Calif.	NULL
)	NULL
.	NULL

Both	NULL
strands	NULL
from	NULL
each	NULL
of	NULL
five	NULL
independent	NULL
clones	NULL
were	NULL
subsequently	NULL
sequenced	NULL
using	NULL
an	NULL
ABI	NULL
PRISM	NULL
377	NULL
automatic	NULL
DNA	NULL
sequencer	NULL
.	NULL

Reporter	NULL
assays	NULL
.	NULL

All	NULL
transfections	NULL
included	NULL
pGKBgal	NULL
,	NULL
which	NULL
expresses	NULL
B-galactosidase	NULL
from	NULL
a	NULL
phosphoglucokinase	NULL
promoter	NULL
,	NULL
together	NULL
with	NULL
3X-	NULL
«	NULL
B-luc	NULL
,	NULL
which	NULL
has	NULL
three	NULL
copies	NULL
of	NULL
the	NULL
NF-kB	NULL
binding	NULL
site	NULL
from	NULL
the	NULL
murine	NULL
major	NULL
histo-compatibility	NULL
complex	NULL
class	NULL
I	NULL
promoter	NULL
upstream	NULL
of	NULL
a	NULL
minimal	NULL
fos	NULL
promoter	NULL
and	NULL
a	NULL
luciferase	NULL
gene	NULL
.	NULL

At	NULL
48	NULL
h	NULL
posttransfection	NULL
,	NULL
cells	NULL
were	NULL
washed	NULL
once	NULL
in	NULL
phosphate-buffered	NULL
saline	NULL
and	NULL
lysed	NULL
in	NULL
200	NULL
pl	NULL
of	NULL
reporter	NULL
lysis	NULL
buffer	NULL
(	NULL
Promega	NULL
,	NULL
Madison	NULL
,	NULL
Wis.	NULL
)	NULL
.	NULL

Assays	NULL
for	NULL
luciferase	NULL
were	NULL
performed	NULL
with	NULL
a	NULL
Luminometer	NULL
by	NULL
using	NULL
a	NULL
luciferase	NULL
assay	NULL
(	NULL
Promega	NULL
)	NULL
.	NULL

Values	NULL
were	NULL
normalized	NULL
to	NULL
B-galactosidase	NULL
activity	NULL
.	NULL

RESULTS	NULL
HVS	NULL
subgroup	NULL
A	NULL
and	NULL
subgroup	NULL
C	NULL
STPs	NULL
interact	NULL
with	NULL
TRAFs	NULL
.	NULL

HVS	NULL
STP-A	NULL
has	NULL
a	NULL
PXQXT	NULL
sequence	NULL
similar	NULL
to	NULL
that	NULL
in	NULL
LMP1	NULL
,	NULL
CD30	NULL
,	NULL
CD40	NULL
and	NULL
TANK	NULL
(	NULL
7	NULL
,	NULL
20	NULL
,	NULL
21	NULL
)	NULL
,	NULL
while	NULL
STP-C488	NULL
and	NULL
STP-C484M	NULL
have	NULL
more	NULL
divergent	NULL
sequences	NULL
with	NULL
glutamic	NULL
acid	NULL
in	NULL
place	NULL
of	NULL
glutamine	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

The	NULL
potential	NULL
interaction	NULL
of	NULL
STP	NULL
with	NULL
TRAFs	NULL
was	NULL
therefore	NULL
investigated	NULL
by	NULL
transfecting	NULL
BOSC23	NULL
cells	NULL
with	NULL
expression	NULL
vectors	NULL
for	NULL
STP-A11l	NULL
or	NULL
STP-C488	NULL
and	NULL
for	NULL
TRAF1	NULL
,	NULL
TRAF2	NULL
,	NULL
or	NULL
TRAF3	NULL
.	NULL

The	NULL
amino	NULL
termini	NULL
of	NULL
the	NULL
TRAFs	NULL
and	NULL
STP-A11	NULL
were	NULL
tagged	NULL
with	NULL
Flag	NULL
and	NULL
AU-1	NULL
epitopes	NULL
,	NULL
respectively	NULL
.	NULL

After	NULL
transfection	NULL
,	NULL
TRAF	NULL
complexes	NULL
were	NULL
precipitated	NULL
with	NULL
an	NULL
anti-Flag	NULL
antibody	NULL
and	NULL
STP-A11	NULL
or	NULL
STP-C488	NULL
was	NULL
detected	NULL
by	NULL
immunoblotting	NULL
.	NULL

STP-C488	NULL
was	NULL
readily	NULL
evident	NULL
at	NULL
20	NULL
kDa	NULL
in	NULL
the	NULL
TRAF	NULL
1	NULL
,	NULL
2	NULL
,	NULL
or	NULL
3	NULL
precipitates	NULL
(	NULL
Fig	NULL
.	NULL

2A	NULL
)	NULL
.	NULL

STP-A11	NULL
was	NULL
expressed	NULL
as	NULL
26-	NULL
and	NULL
35-kDa	NULL
proteins	NULL
(	NULL
34	NULL
)	NULL
.	NULL

STP-A11	NULL
and	NULL
STP-C488	NULL
were	NULL
not	NULL
detected	NULL
in	NULL
precipitates	NULL
from	NULL
negative	NULL
control	NULL
cell	NULL
lysates	NULL
(	NULL
Fig	NULL
.	NULL

2A	NULL
and	NULL
B	NULL
,	NULL
lanes	NULL
2	NULL
)	NULL
.	NULL

These	NULL
tests	NULL
demonstrate	NULL
that	NULL
STP-A1l	NULL
and	NULL
STP-C488	NULL
interacted	NULL
specifically	NULL
with	NULL
TRAFs	NULL
in	NULL
BOSC23	NULL
cells	NULL
.	NULL

Different	NULL
regions	NULL
of	NULL
TRAF	NULL
are	NULL
required	NULL
for	NULL
binding	NULL
to	NULL
STP-A	NULL
and	NULL
STP-C.	NULL
To	NULL
confirm	NULL
that	NULL
TRAFs	NULL
bind	NULL
through	NULL
their	NULL
voL	NULL
.	NULL

73	NULL
,	NULL
1999	NULL
TRAF-binding	NULL
motif	NULL
PXQXT/S	NULL
TANK	NULL
i	NULL
»	NULL
QCSVPIQCTDEKTEKQ	NULL
)	NULL
$	NULL
$	NULL
CD30	NULL
ss	NULL
TPHYPEQETEPPLGS	NULL
;	NULL
;	NULL
,	NULL
CD40	NULL
j	NULL
,	NULL
Human	NULL
EBV	NULL
LMP1	NULL
20SLPHPQQATDDSGHEq	NULL
;	NULL
,	NULL
Baboon	NULL
EBV	NULL
LMP1	NULL
;	NULL
,	NULL
DPHPPVQETGGGGSG	NULL
;	NULL
;	NULL
;	NULL
Rhesus	NULL
EBV	NULL
LMP1	NULL
3	NULL
HLPHPVQASDGGDGL	NULL
y	NULL
;	NULL
;	NULL
HVS	NULL
STP-A1l	NULL
seLLGHPVQESGCPGRP	NULL
;	NULL
,	NULL
HVS	NULL
STP-OMI	NULL
sLLGHPVQETGSPGRP	NULL
;	NULL
,	NULL
HVS	NULL
STP-C484M	NULL
@	NULL
NLRYPTEETGDRGPP	NULL
;	NULL
,	NULL
HVS	NULL
STP-C488	NULL
[	NULL
NLRYPIEETGDRGPP	NULL
;	NULL
,	NULL
FIG	NULL
.	NULL

1	NULL
.	NULL

Sequence	NULL
comparison	NULL
of	NULL
the	NULL
amino-terminal	NULL
regions	NULL
of	NULL
STPs	NULL
with	NULL
TRAF	NULL
binding	NULL
motifs	NULL
.	NULL

The	NULL
sequences	NULL
of	NULL
the	NULL
amino-terminal	NULL
regions	NULL
of	NULL
STPs	NULL
from	NULL
HVS	NULL
subgroup	NULL
A	NULL
and	NULL
C	NULL
strains	NULL
were	NULL
aligned	NULL
with	NULL
TRAF-binding	NULL
motifs	NULL
of	NULL
LMP1	NULL
,	NULL
CD30	NULL
,	NULL
CD40	NULL
,	NULL
and	NULL
TANK	NULL
.	NULL

STP-A11	NULL
and	NULL
STP-OMI	NULL
belong	NULL
to	NULL
subgroup	NULL
A	NULL
,	NULL
and	NULL
STP-C484M	NULL
and	NULL
STP-C488	NULL
belong	NULL
to	NULL
subgroup	NULL
C.	NULL
Bold	NULL
letters	NULL
indicate	NULL
the	NULL
conserved	NULL
amino	NULL
acid	NULL
sequence	NULL
.	NULL

TRAF-C	NULL
domain	NULL
to	NULL
the	NULL
STP-A11	NULL
or	NULL
STP-C488	NULL
,	NULL
we	NULL
evaluated	NULL
the	NULL
association	NULL
of	NULL
STP-A1l	NULL
or	NULL
STP-C488	NULL
with	NULL
TRAF3-C	NULL
,	NULL
which	NULL
contains	NULL
the	NULL
TRAF-C	NULL
domain	NULL
only	NULL
,	NULL
or	NULL
with	NULL
TRAF3	NULL
AC	NULL
}	NULL
,	NULL
from	NULL
which	NULL
the	NULL
TRAF-C	NULL
domain	NULL
has	NULL
been	NULL
deleted	NULL
.	NULL

Flag-tagged	NULL
TRAF3	NULL
,	NULL
TRAF3	NULL
AC	NULL
,	NULL
or	NULL
TRAF3-C	NULL
was	NULL
expressed	NULL
in	NULL
COS-1	NULL
cells	NULL
along	NULL
with	NULL
STP-A11	NULL
or	NULL
STP-C488	NULL
.	NULL

Anti-Flag	NULL
antibody	NULL
was	NULL
used	NULL
to	NULL
precipitate	NULL
TRAF	NULL
complexes	NULL
from	NULL
cell	NULL
lysates	NULL
.	NULL

TRAF3-C	NULL
bound	NULL
to	NULL
STP-A11	NULL
as	NULL
efficiently	NULL
as	NULL
wild-type	NULL
(	NULL
wt	NULL
)	NULL
TRAF3	NULL
,	NULL
whereas	NULL
the	NULL
TRAF3	NULL
AC	NULL
did	NULL
not	NULL
bind	NULL
to	NULL
STP-A11	NULL
(	NULL
Fig	NULL
.	NULL

3A	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
both	NULL
TRAF3-C	NULL
and	NULL
TRAF3	NULL
AC	NULL
failed	NULL
to	NULL
bind	NULL
to	NULL
STP-C488	NULL
,	NULL
while	NULL
wt	NULL
TRAF3	NULL
bound	NULL
efficiently	NULL
to	NULL
STP-C488	NULL
.	NULL

Under	NULL
these	NULL
conditions	NULL
,	NULL
similar	NULL
amounts	NULL
of	NULL
TRAF3	NULL
,	NULL
TRAF3-C	NULL
,	NULL
and	NULL
TRAF3	NULL
AC	NULL
and	NULL
of	NULL
STP-A1l	NULL
and	NULL
STP-C488	NULL
were	NULL
expressed	NULL
in	NULL
COS-1	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

These	NULL
results	NULL
demonstrate	NULL
that	NULL
the	NULL
TRAF-C	NULL
domain	NULL
is	NULL
necessary	NULL
and	NULL
sufficient	NULL
for	NULL
its	NULL
binding	NULL
to	NULL
STP-A11	NULL
,	NULL
as	NULL
it	NULL
is	NULL
for	NULL
its	NULL
binding	NULL
to	NULL
CD40	NULL
or	NULL
LMP1	NULL
,	NULL
while	NULL
a	NULL
domain	NULL
(	NULL
s	NULL
)	NULL
in	NULL
addition	NULL
to	NULL
the	NULL
TRAF-C	NULL
domain	NULL
is	NULL
necessary	NULL
for	NULL
binding	NULL
to	NULL
STP-C488	NULL
.	NULL

A	NULL
.	NULL

B.	NULL
LB	NULL
.	NULL

__	NULL
Aid	NULL
LB	NULL
.	NULL

__AU4	NULL
LP	NULL
.	NULL

flag	NULL
LP	NULL
.	NULL

fla	NULL
12	NULL
s	NULL
4	NULL
5	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
45-	NULL
45	NULL
30-	NULL
30	NULL
.	NULL

20	NULL
m	NULL
20	NULL
14-	NULL
14	NULL
``	NULL
o=	NULL
S	NULL
>	NULL
:	NULL
}	NULL
STP	NULL
'	NULL
A	NULL
‘	NULL
1	NULL
a	NULL
>	NULL
-	NULL
ase	NULL
dig	NULL
**	NULL
;	NULL
TRAF	NULL
o	NULL
wB	NULL
``	NULL
``	NULL
~~	NULL
``	NULL
TRAF	NULL
+	NULL
-	NULL
+	NULL
>	NULL
>	NULL
TRAFI	NULL
£	NULL
-	NULL
#	NULL
>	NULL
>	NULL
TRAFR	NULL
-	NULL
-	NULL
-	NULL
4+	NULL
-	NULL
-	NULL
~	NULL
-	NULL
+	NULL
>	NULL
TRaF®	NULL
-	NULL
-	NULL
-	NULL
>	NULL
+	NULL
TRaF®	NULL
-	NULL
-	NULL
-	NULL
>	NULL
+	NULL
STP-C488	NULL
-	NULL
+	NULL
+	NULL
++	NULL
STPAI	NULL
-	NULL
4	NULL
+	NULL
+	NULL
o+	NULL
FIG	NULL
.	NULL

2	NULL
.	NULL

Interaction	NULL
of	NULL
STP	NULL
with	NULL
TRAF	NULL
.	NULL

BOSC23	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
STP-A1l	NULL
or	NULL
STP-C488	NULL
expression	NULL
vector	NULL
together	NULL
with	NULL
TRAF1	NULL
,	NULL
TRAF2	NULL
,	NULL
or	NULL
TRAF3	NULL
expression	NULL
vector	NULL
as	NULL
shown	NULL
at	NULL
the	NULL
bottom	NULL
of	NULL
the	NULL
figure	NULL
.	NULL

After	NULL
48	NULL
h	NULL
,	NULL
cell	NULL
extracts	NULL
were	NULL
used	NULL
for	NULL
immunoprecipitation	NULL
(	NULL
LP	NULL
.	NULL
)	NULL

with	NULL
Flag	NULL
antibody	NULL
(	NULL
flag	NULL
)	NULL
.	NULL

The	NULL
upper	NULL
panels	NULL
show	NULL
Flag	NULL
immune	NULL
complexes	NULL
that	NULL
were	NULL
subjected	NULL
to	NULL
immunoblot	NULL
assay	NULL
(	NULL
LB	NULL
.	NULL
)	NULL

with	NULL
A1l.4	NULL
antibody	NULL
to	NULL
detect	NULL
STP-C488	NULL
(	NULL
A	NULL
)	NULL
or	NULL
AU-1	NULL
antibody	NULL
to	NULL
detect	NULL
STP-A11	NULL
(	NULL
B	NULL
)	NULL
.	NULL

The	NULL
expression	NULL
levels	NULL
of	NULL
TRAFs	NULL
(	NULL
bottom	NULL
panel	NULL
)	NULL
and	NULL
STP-All	NULL
or	NULL
STP-C488	NULL
(	NULL
middle	NULL
panel	NULL
)	NULL
in	NULL
BOSC23	NULL
cells	NULL
were	NULL
evaluated	NULL
by	NULL
immunoblotting	NULL
with	NULL
the	NULL
specific	NULL
antibodies	NULL
,	NULL
and	NULL
the	NULL
results	NULL
are	NULL
shown	NULL
in	NULL
the	NULL
bottom	NULL
two	NULL
panels	NULL
of	NULL
the	NULL
figure	NULL
.	NULL

The	NULL
asterisk	NULL
indicates	NULL
the	NULL
light	NULL
chains	NULL
of	NULL
immunoglobulin	NULL
.	NULL

CELLULAR	NULL
TRAFs	NULL
IN	NULL
T-CELL	NULL
TRANSFORMATION	NULL
BY	NULL
HVS	NULL
STP	NULL
-	NULL
3915	NULL
Cue	NULL
tune	NULL
C604	NULL
tema	NULL
CD	NULL
Amat	NULL
Au	NULL
©	NULL
K	NULL
%	NULL
.	NULL

<	NULL
-	NULL
STP-C488	NULL
C	NULL
LB	NULL
.	NULL

flag	NULL
(	NULL
ro	NULL
e	NULL
s	NULL
40	NULL
s	NULL
r	NULL
os	NULL
e	NULL
t	NULL
cum	NULL
<	NULL
-	NULL
TRAF3	NULL
eg	NULL
cn	NULL
»	NULL
«	NULL
ant	NULL
<	NULL
-	NULL
TRAF3	NULL
AC	NULL
D.	NULL
10	NULL
20	NULL
os	NULL
04005	NULL
s	NULL
00	NULL
7	NULL
8	NULL
oa	NULL
camas	NULL
came	NULL
<	NULL
-	NULL
STP-A11	NULL
_*	NULL
E	NULL
10	NULL
r	NULL
os	NULL
0	NULL
40050060	NULL
0T	NULL
os	NULL
oa	NULL
ge	NULL
p	NULL
he	NULL
-str-ciuss	NULL
FIG	NULL
.	NULL

3	NULL
.	NULL

Different	NULL
regions	NULL
of	NULL
TRAF	NULL
are	NULL
required	NULL
for	NULL
binding	NULL
to	NULL
STP-A11	NULL
and	NULL
STP-C488	NULL
.	NULL

COS-1	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
TRAF3	NULL
(	NULL
lanes	NULL
1	NULL
,	NULL
2	NULL
,	NULL
and	NULL
3	NULL
)	NULL
,	NULL
TRAF3	NULL
AC	NULL
(	NULL
lanes	NULL
4	NULL
,	NULL
5	NULL
,	NULL
and	NULL
6	NULL
)	NULL
,	NULL
or	NULL
TRAF3-C	NULL
(	NULL
lanes	NULL
7	NULL
,	NULL
8	NULL
,	NULL
and	NULL
9	NULL
)	NULL
together	NULL
with	NULL
STP-A11	NULL
(	NULL
lanes	NULL
2	NULL
,	NULL
5	NULL
,	NULL
and	NULL
8	NULL
)	NULL
or	NULL
STP-C488	NULL
(	NULL
lanes	NULL
3	NULL
,	NULL
6	NULL
,	NULL
and	NULL
9	NULL
)	NULL
expression	NULL
vector	NULL
.	NULL

After	NULL
48	NULL
h	NULL
,	NULL
cell	NULL
lysates	NULL
were	NULL
used	NULL
for	NULL
immunoprecipitation	NULL
with	NULL
Flag	NULL
antibody	NULL
(	NULL
flag	NULL
)	NULL
(	NULL
A	NULL
and	NULL
B	NULL
)	NULL
.	NULL

The	NULL
immune	NULL
complex	NULL
was	NULL
subjected	NULL
to	NULL
immunoblot	NULL
assay	NULL
(	NULL
LB	NULL
.	NULL
)	NULL

with	NULL
AU-1	NULL
antibody	NULL
to	NULL
detect	NULL
STP-A11	NULL
(	NULL
A	NULL
)	NULL
or	NULL
A1.4	NULL
antibody	NULL
to	NULL
detect	NULL
STP-C488	NULL
(	NULL
B	NULL
)	NULL
.	NULL

The	NULL
expression	NULL
levels	NULL
of	NULL
TRAF	NULL
(	NULL
C	NULL
)	NULL
,	NULL
STP-A11	NULL
(	NULL
D	NULL
)	NULL
,	NULL
and	NULL
STP-C488	NULL
(	NULL
E	NULL
)	NULL
were	NULL
demonstrated	NULL
by	NULL
immunoblotting	NULL
of	NULL
cell	NULL
lysates	NULL
with	NULL
specific	NULL
antibodies	NULL
.	NULL

Asterisks	NULL
indicate	NULL
the	NULL
heavy	NULL
and	NULL
light	NULL
chains	NULL
of	NULL
immunoglobulin	NULL
,	NULL
and	NULL
arrows	NULL
indicate	NULL
each	NULL
protein	NULL
as	NULL
labelled	NULL
.	NULL

Mutational	NULL
analysis	NULL
of	NULL
the	NULL
putative	NULL
STP-A11	NULL
and	NULL
STP-C488	NULL
TRAF	NULL
binding	NULL
motifs	NULL
.	NULL

To	NULL
investigate	NULL
whether	NULL
the	NULL
putative	NULL
STP	NULL
TRAF	NULL
binding	NULL
motif	NULL
is	NULL
required	NULL
for	NULL
TRAF	NULL
association	NULL
,	NULL
two	NULL
point	NULL
mutations	NULL
in	NULL
the	NULL
putative	NULL
TRAF	NULL
binding	NULL
motif	NULL
in	NULL
STP-All	NULL
were	NULL
generated	NULL
by	NULL
site-directed	NULL
mutagenesis	NULL
;	NULL
codon	NULL
60	NULL
was	NULL
deleted	NULL
from	NULL
one	NULL
mutant	NULL
(	NULL
STP-A11	NULL
AP4	NULL
,	NULL
)	NULL
and	NULL
glutamine	NULL
encoded	NULL
by	NULL
codon	NULL
62	NULL
was	NULL
replaced	NULL
by	NULL
alanine	NULL
in	NULL
a	NULL
second	NULL
mutant	NULL
(	NULL
STP-A1l	NULL
Q	NULL
&	NULL
,	NULL
/A	NULL
)	NULL
.	NULL

Seven	NULL
STP-C488	NULL
mutants	NULL
(	NULL
P	NULL
;	NULL
y/R	NULL
,	NULL
/K	NULL
,	NULL
£E12E,3/6G	NULL
,	NULL
T/A	NULL
,	NULL
M1	NULL
,	NULL
ANp	NULL
;	NULL
,	NULL
and	NULL
A2-17	NULL
)	NULL
described	NULL
previously	NULL
(	NULL
25	NULL
,	NULL
26	NULL
)	NULL
were	NULL
also	NULL
evaluated	NULL
for	NULL
the	NULL
TRAF	NULL
binding	NULL
activity	NULL
.	NULL

P	NULL
:	NULL
y/R	NULL
,	NULL
I	NULL
;	NULL
/K	NULL
,	NULL
E1	NULL
;	NULL
£,7/GG	NULL
,	NULL
and	NULL
T	NULL
,	NULL
/A	NULL
are	NULL
point	NULL
mutations	NULL
in	NULL
the	NULL
putative	NULL
TRAF	NULL
binding	NULL
motif	NULL
.	NULL

A2-17	NULL
is	NULL
deleted	NULL
for	NULL
amino-terminal	NULL
residues	NULL
2	NULL
to	NULL
17	NULL
,	NULL
M1	NULL
has	NULL
a	NULL
three-amino-acid	NULL
insertion	NULL
in	NULL
the	NULL
collagen	NULL
repeats	NULL
,	NULL
and	NULL
AN	NULL
,	NULL
;	NULL
is	NULL
deleted	NULL
for	NULL
the	NULL
carboxyl-terminal	NULL
amino	NULL
acid	NULL
(	NULL
25	NULL
,	NULL
26	NULL
)	NULL
.	NULL

A2-17	NULL
and	NULL
M1	NULL
mutants	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
defective	NULL
in	NULL
Rat-1	NULL
transformation	NULL
,	NULL
whereas	NULL
AN	NULL
;	NULL
,	NULL
,	NULL
mutant	NULL
shows	NULL
wt	NULL
Rat-1	NULL
transformation	NULL
(	NULL
25	NULL
,	NULL
26	NULL
)	NULL
.	NULL

After	NULL
cotransfection	NULL
of	NULL
the	NULL
STP	NULL
genes	NULL
and	NULL
the	NULL
TRAF2	NULL
genes	NULL
into	NULL
BOSC23	NULL
cells	NULL
,	NULL
an	NULL
anti-Flag	NULL
antibody	NULL
was	NULL
used	NULL
to	NULL
precipitate	NULL
TRAF	NULL
complexes	NULL
.	NULL

The	NULL
AP	NULL
;	NULL
,	NULL
and	NULL
Q	NULL
,	NULL
,	NULL
/A	NULL
mutations	NULL
in	NULL
the	NULL
STP-A1l	NULL
PXQXT	NULL
motif	NULL
abolished	NULL
complex	NULL
formation	NULL
with	NULL
TRAF2	NULL
(	NULL
Fig	NULL
.	NULL

4A	NULL
)	NULL
.	NULL

Under	NULL
these	NULL
conditions	NULL
,	NULL
similar	NULL
amounts	NULL
of	NULL
STP-A1l	NULL
and	NULL
its	NULL
mutants	NULL
were	NULL
expressed	NULL
.	NULL

The	NULL
STP-C488	NULL
P	NULL
;	NULL
y/R	NULL
,	NULL
L	NULL
/K	NULL
,	NULL
and	NULL
AZ2-17	NULL
mutations	NULL
also	NULL
abrogated	NULL
TRAF	NULL
binding	NULL
activity	NULL
,	NULL
whereas	NULL
the	NULL
E	NULL
;	NULL
,	NULL
F	NULL
,	NULL
,	NULL
/GG	NULL
,	NULL
T	NULL
,	NULL
,	NULL
/A	NULL
,	NULL
MI	NULL
,	NULL
and	NULL
3916	NULL
_	NULL
LEE	NULL
ET	NULL
AL	NULL
.	NULL

A.	NULL
LB	NULL
.	NULL

__	NULL
AUA	NULL
B	NULL
LP	NULL
flad	NULL
1	NULL
23	NULL
4	NULL
5	NULL
so	NULL
'	NULL
*	NULL
w	NULL
a5-30-	NULL
®	NULL
fed	NULL
20	NULL
-__	NULL
CEE	NULL
ao	NULL
_	NULL
_	NULL
»	NULL
as	NULL
as	NULL
_|	NULL
TRAF	NULL
2	NULL
TRAFZ	NULL
+	NULL
-§é§a	NULL
cegy	NULL
+	NULL
STP-A11	NULL
J.	NULL
Virou	NULL
.	NULL

1B	NULL
.	NULL

A14	NULL
LP	NULL
.	NULL

fla	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
,	NULL
a	NULL
K1	NULL
_s	NULL
iz	NULL
30-20-	NULL
’	NULL
‘	NULL
l-n	NULL
``	NULL
14-	NULL
:	NULL
~	NULL
©	NULL
es-s0-	NULL
-w	NULL
@	NULL
B	NULL
~	NULL
>	NULL
TRAFZ	NULL
4	NULL
%	NULL
-	NULL
+	NULL
+	NULL
+	NULL
4+	NULL
+	NULL
+	NULL
+	NULL
+	NULL
STP-C4s8	NULL
-	NULL
&	NULL
P19	NULL
25	NULL
,	NULL
fel	NULL
6	NULL
FIG	NULL
.	NULL

4	NULL
.	NULL

Mutational	NULL
analysis	NULL
of	NULL
STP-A11	NULL
and	NULL
STP-C488	NULL
for	NULL
binding	NULL
to	NULL
TRAF	NULL
.	NULL

BOSC23	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
STP-A11	NULL
mutants	NULL
(	NULL
A	NULL
)	NULL
or	NULL
STP-C488	NULL
mutants	NULL
(	NULL
B	NULL
)	NULL
together	NULL
with	NULL
TRAF2	NULL
expression	NULL
vector	NULL
as	NULL
indicated	NULL
at	NULL
the	NULL
bottom	NULL
of	NULL
the	NULL
figure	NULL
.	NULL

Cell	NULL
lysates	NULL
were	NULL
used	NULL
for	NULL
immunoprecipitation	NULL
(	NULL
LP	NULL
.	NULL
)	NULL

with	NULL
Flag	NULL
antibody	NULL
(	NULL
flag	NULL
)	NULL
,	NULL
followed	NULL
by	NULL
an	NULL
immunoblot	NULL
assay	NULL
(	NULL
.B	NULL
.	NULL
)	NULL

with	NULL
AU-1	NULL
antibody	NULL
to	NULL
detect	NULL
STP-A11	NULL
(	NULL
top	NULL
panel	NULL
of	NULL
A	NULL
)	NULL
or	NULL
A1.4	NULL
antibody	NULL
to	NULL
detect	NULL
STP-C488	NULL
(	NULL
top	NULL
panel	NULL
of	NULL
B	NULL
)	NULL
.	NULL

The	NULL
levels	NULL
of	NULL
STPs	NULL
and	NULL
TRAF2	NULL
expression	NULL
were	NULL
demonstrated	NULL
by	NULL
immunoblotting	NULL
with	NULL
their	NULL
specific	NULL
antibodies	NULL
as	NULL
indicated	NULL
at	NULL
the	NULL
bottom	NULL
of	NULL
the	NULL
figure	NULL
.	NULL

AN	NULL
,	NULL
,	NULL
mutations	NULL
did	NULL
not	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
)	NULL
.	NULL

Despite	NULL
weak	NULL
expression	NULL
,	NULL
the	NULL
AN	NULL
;	NULL
,	NULL
,	NULL
mutant	NULL
was	NULL
readily	NULL
detected	NULL
in	NULL
TRAF	NULL
complexes	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
)	NULL
.	NULL

The	NULL
STP-C488	NULL
mutants	NULL
migrated	NULL
somewhat	NULL
anom-alously	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
)	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
26	NULL
)	NULL
.	NULL

These	NULL
results	NULL
indicate	NULL
that	NULL
the	NULL
STP-A1l	NULL
putative	NULL
TRAF	NULL
binding	NULL
motif	NULL
is	NULL
important	NULL
for	NULL
TRAF	NULL
association	NULL
.	NULL

Furthermore	NULL
,	NULL
the	NULL
STP-C488	NULL
putative	NULL
TRAF	NULL
binding	NULL
motif	NULL
appears	NULL
to	NULL
be	NULL
part	NULL
of	NULL
the	NULL
TRAF	NULL
binding	NULL
domain	NULL
.	NULL

However	NULL
,	NULL
only	NULL
the	NULL
amino-terminal	NULL
P	NULL
;	NULL
,	NULL
and	NULL
I	NULL
;	NULL
;	NULL
residues	NULL
of	NULL
the	NULL
core	NULL
site	NULL
appear	NULL
to	NULL
be	NULL
critical	NULL
for	NULL
TRAF	NULL
.	NULL

STP-C488	NULL
activates	NULL
NF-KB	NULL
activity	NULL
.	NULL

Since	NULL
TRAF2	NULL
can	NULL
mediate	NULL
NF-KB	NULL
activation	NULL
by	NULL
EBV	NULL
LMP1	NULL
or	NULL
TNF	NULL
receptors	NULL
(	NULL
24	NULL
,	NULL
38	NULL
,	NULL
43	NULL
)	NULL
,	NULL
we	NULL
have	NULL
investigated	NULL
the	NULL
effect	NULL
of	NULL
STP-C488	NULL
expression	NULL
on	NULL
NF-kB	NULL
activation	NULL
in	NULL
293	NULL
cells	NULL
by	NULL
using	NULL
an	NULL
NF-	NULL
«	NULL
B-driven	NULL
luciferase	NULL
reporter	NULL
plasmid	NULL
,	NULL
3X-kB-L	NULL
,	NULL
and	NULL
a	NULL
control	NULL
B-galactosidase	NULL
expression	NULL
plasmid	NULL
,	NULL
pGKBgal	NULL
.	NULL

Relative	NULL
luciferase	NULL
values	NULL
were	NULL
normalized	NULL
to	NULL
B-galactosidase	NULL
activity	NULL
for	NULL
transfection	NULL
efficiency	NULL
.	NULL

Three	NULL
independent	NULL
assays	NULL
showed	NULL
that	NULL
wt	NULL
STP-C488	NULL
increased	NULL
NF-kB	NULL
activity	NULL
approximately	NULL
3.5-	NULL
to	NULL
6-fold	NULL
.	NULL

The	NULL
STP-C488	NULL
E	NULL
;	NULL
,	NULL
E	NULL
,	NULL
/GG	NULL
,	NULL
T	NULL
,	NULL
,	NULL
/A	NULL
,	NULL
and	NULL
M1	NULL
mutants	NULL
were	NULL
similar	NULL
to	NULL
wt	NULL
STP-C488	NULL
,	NULL
whereas	NULL
no	NULL
activation	NULL
was	NULL
induced	NULL
by	NULL
the	NULL
STP-C488	NULL
PiyR	NULL
:	NULL
,	NULL
P10/Q	NULL
Pio/L	NULL
114/E	NULL
.	NULL

,	NULL
L	NULL
/K	NULL
,	NULL
or	NULL
A2-17	NULL
mutants	NULL
(	NULL
Fig	NULL
.	NULL

5A	NULL
)	NULL
.	NULL

Luciferase	NULL
activity	NULL
required	NULL
a	NULL
wt	NULL
NF-kB	NULL
element	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

These	NULL
results	NULL
indicate	NULL
that	NULL
STP-C488	NULL
can	NULL
activate	NULL
NF-kB	NULL
activity	NULL
and	NULL
that	NULL
this	NULL
activity	NULL
is	NULL
dependent	NULL
upon	NULL
the	NULL
STP-C488	NULL
amino	NULL
terminus	NULL
,	NULL
including	NULL
P	NULL
;	NULL
,	NULL
and	NULL
I	NULL
,	NULL
,	NULL
,	NULL
which	NULL
are	NULL
critical	NULL
for	NULL
TRAF	NULL
association	NULL
.	NULL

In	NULL
striking	NULL
contrast	NULL
,	NULL
STP-A11l	NULL
did	NULL
not	NULL
induce	NULL
NF-kB	NULL
activation	NULL
under	NULL
the	NULL
same	NULL
conditions	NULL
(	NULL
Fig	NULL
.	NULL

5A	NULL
)	NULL
.	NULL

Generation	NULL
of	NULL
HVS	NULL
STP-C488	NULL
P	NULL
,	NULL
;	NULL
,	NULL
-R	NULL
recombinant	NULL
.	NULL

To	NULL
investigate	NULL
the	NULL
importance	NULL
of	NULL
the	NULL
TRAF-binding	NULL
activity	NULL
of	NULL
STP	NULL
in	NULL
virus-induced	NULL
transformation	NULL
,	NULL
we	NULL
constructed	NULL
a	NULL
recombinant	NULL
HVS	NULL
C488	NULL
with	NULL
the	NULL
STP-C488	NULL
P	NULL
;	NULL
,	NULL
-R	NULL
mutation	NULL
,	NULL
which	NULL
disrupts	NULL
TRAF	NULL
association	NULL
and	NULL
NF-kB	NULL
activation	NULL
.	NULL

The	NULL
parental	NULL
virion	NULL
DNA	NULL
from	NULL
which	NULL
the	NULL
mutant	NULL
was	NULL
constructed	NULL
had	NULL
a	NULL
SEAP	NULL
reporter	NULL
expression	NULL
cassette	NULL
in	NULL
place	NULL
of	NULL
the	NULL
STP-C488	NULL
gene	NULL
and	NULL
is	NULL
nontransforming	NULL
in	NULL
culture	NULL
and	NULL
nononcogenic	NULL
in	NULL
common	NULL
marmosets	NULL
(	NULL
14	NULL
)	NULL
.	NULL

After	NULL
cotransfection	NULL
with	NULL
the	NULL
parental	NULL
virion	NULL
DNA	NULL
and	NULL
a	NULL
linearized	NULL
plasmid	NULL
containing	NULL
the	NULL
P	NULL
;	NULL
,	NULL
-R	NULL
mutation	NULL
in	NULL
STP-C488	NULL
in	NULL
the	NULL
context	NULL
of	NULL
a	NULL
flanking	NULL
sequence	NULL
homologous	NULL
to	NULL
the	NULL
parental	NULL
DNA	NULL
,	NULL
SEAP-negative	NULL
virus	NULL
was	NULL
isolated	NULL
by	NULL
limiting	NULL
dilution	NULL
.	NULL

PCR	NULL
and	NULL
sequence	NULL
analysis	NULL
confirmed	NULL
the	NULL
presence	NULL
of	NULL
STP-C488	NULL
P	NULL
;	NULL
,	NULL
-	NULL
>	NULL
R	NULL
in	NULL
the	NULL
putative	NULL
recombinant	NULL
virus	NULL
;	NULL
the	NULL
rest	NULL
of	NULL
the	NULL
STP-C488	NULL
open	NULL
reading	NULL
frame	NULL
was	NULL
confirmed	NULL
to	NULL
be	NULL
of	NULL
the	NULL
wt	NULL
.	NULL

Transforming	NULL
activity	NULL
of	NULL
recombinant	NULL
HVS	NULL
STP-C488	NULL
P	NULL
;	NULL
,	NULL
-R	NULL
in	NULL
common	NULL
marmosets	NULL
.	NULL

Primary	NULL
common	NULL
marmoset	NULL
T	NULL
lymphocytes	NULL
were	NULL
infected	NULL
with	NULL
recombinant	NULL
HVS	NULL
STP-C488	NULL
P	NULL
;	NULL
;	NULL
-R	NULL
,	NULL
wt	NULL
HVS	NULL
,	NULL
or	NULL
the	NULL
parental	NULL
HVS	NULL
ASTP-SV40-SEAP	NULL
.	NULL

HVS	NULL
,	NULL
HVS	NULL
ASTP-SV40-SEAP	NULL
,	NULL
and	NULL
HVS	NULL
STP-C488	NULL
P	NULL
;	NULL
j	NULL
,	NULL
-R	NULL
at	NULL
equivalent	NULL
titers	NULL
were	NULL
separately	NULL
added	NULL
to	NULL
individually	NULL
purified	NULL
,	NULL
unstimulated	NULL
,	NULL
common	NULL
marmoset	NULL
PBMCs	NULL
.	NULL

HVS	NULL
STP-C488	NULL
P	NULL
,	NULL
,	NULL
-	NULL
>	NULL
R	NULL
immortalized	NULL
marmoset	NULL
primary	NULL
T	NULL
lymphocytes	NULL
to	NULL
IL-2-independent	NULL
growth	NULL
within	NULL
about	NULL
1	NULL
month	NULL
postinfection	NULL
and	NULL
was	NULL
similar	NULL
to	NULL
wt	NULL
HVS	NULL
in	NULL
immortalizing	NULL
efficiency	NULL
,	NULL
whereas	NULL
HVS	NULL
ASTP-SV40-SEAP	NULL
was	NULL
unable	NULL
to	NULL
immortalize	NULL
the	NULL
marmoset	NULL
T	NULL
cells	NULL
(	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

HVS	NULL
STP-C488	NULL
P	NULL
;	NULL
j-R	NULL
was	NULL
also	NULL
compared	NULL
with	NULL
wt	NULL
HVS	NULL
in	NULL
experimental	NULL
common	NULL
marmoset	NULL
infection	NULL
.	NULL

HVS	NULL
STP-C488	NULL
P	NULL
;	NULL
,	NULL
-	NULL
>	NULL
R	NULL
and	NULL
wt	NULL
HVS	NULL
caused	NULL
fatal	NULL
lymphoproliferative	NULL
disease	NULL
with	NULL
a	NULL
roughly	NULL
equivalent	NULL
time	NULL
course	NULL
.	NULL

Animals	NULL
infected	NULL
with	NULL
wt	NULL
HVS	NULL
became	NULL
moribund	NULL
and	NULL
were	NULL
sacrificed	NULL
on	NULL
days	NULL
19	NULL
and	NULL
20	NULL
;	NULL
animals	NULL
infected	NULL
with	NULL
HVS	NULL
STP-C488	NULL
P	NULL
;	NULL
,	NULL
became	NULL
moribund	NULL
and	NULL
were	NULL
sacrificed	NULL
on	NULL
day	NULL
20	NULL
postinfection	NULL
(	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

Necropsies	NULL
of	NULL
these	NULL
animals	NULL
revealed	NULL
multicentric	NULL
lymphoma	NULL
that	NULL
is	NULL
consistent	NULL
with	NULL
previously	NULL
described	NULL
HVS-induced	NULL
pathology	NULL
(	NULL
9	NULL
)	NULL
.	NULL

HVS	NULL
STP-C488	NULL
P	NULL
;	NULL
,	NULL
lymphoma	NULL
was	NULL
indistinguishable	NULL
from	NULL
that	NULL
induced	NULL
by	NULL
wt	NULL
HVS	NULL
.	NULL

To	NULL
confirm	NULL
that	NULL
HVS	NULL
STP-C488	NULL
P	NULL
;	NULL
,	NULL
-	NULL
>	NULL
R	NULL
was	NULL
present	NULL
in	NULL
the	NULL
transformed	NULL
common	NULL
marmoset	NULL
lymphocytes	NULL
from	NULL
tumor-bearing	NULL
animals	NULL
and	NULL
in	NULL
in	NULL
vitro-immortalized	NULL
cells	NULL
,	NULL
the	NULL
lymphocytes	NULL
were	NULL
cocultivated	NULL
with	NULL
OMK	NULL
cells	NULL
.	NULL

Virus	NULL
preparations	NULL
were	NULL
made	NULL
from	NULL
supernatant	NULL
media	NULL
and	NULL
tested	NULL
by	NULL
PCR	NULL
for	NULL
STP-C488	NULL
DNA	NULL
.	NULL

The	NULL
DNA	NULL
sequencing	NULL
of	NULL
five	NULL
independent	NULL
clones	NULL
of	NULL
amplified	NULL
DNA	NULL
confirmed	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
P	NULL
;	NULL
;	NULL
-R	NULL
mutation	NULL
.	NULL

These	NULL
results	NULL
indicated	NULL
that	NULL
recombinant	NULL
HVS	NULL
STP-C488	NULL
P	NULL
;	NULL
,	NULL
-R	NULL
was	NULL
fully	NULL
capable	NULL
of	NULL
immortalizing	NULL
Vou	NULL
.	NULL

73	NULL
,	NULL
1999	NULL
o	NULL
A.	NULL
c	NULL
8	NULL
o	NULL
57	NULL
B	NULL
€	NULL
8	NULL
g	NULL
5	NULL
i	NULL
3134	NULL
§	NULL
s	NULL
§	NULL
>	NULL
®	NULL
v	NULL
|	NULL
IC	NULL
o	NULL
8	NULL
E	NULL
§	NULL
tdeEer¥=¥_8§§	NULL
8	NULL
E	NULL
9	NULL
9	NULL
at	NULL
a	NULL
a	NULL
42	NULL
-e	NULL
2	NULL
>	NULL
Rood	NULL
ul	NULL
(	NULL
115	NULL
;	NULL
Inf	NULL
!	NULL

6	NULL
B	NULL
.	NULL

14	NULL
6	NULL
5	NULL
0	NULL
3	NULL
B	NULL
4	NULL
©	NULL
PA	NULL
§	NULL
3	NULL
£	NULL
'	NULL
o	NULL
3	NULL
2	NULL
0	NULL
2	NULL
®	NULL
1	NULL
®	NULL
CC	NULL
0	NULL
1	NULL
2	NULL
3	NULL
4	NULL
C	NULL
no	NULL
TNFo	NULL
_	NULL
MW	NULL
thro	NULL
FIG	NULL
.	NULL

5	NULL
.	NULL

Activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
activity	NULL
by	NULL
STP	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
activity	NULL
by	NULL
STP	NULL
.	NULL

293	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
STP-A1l	NULL
,	NULL
STP-C488	NULL
,	NULL
or	NULL
mutant	NULL
STP-C488	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Suppression	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
by	NULL
the	NULL
dominant-negative	NULL
TRAF2	NULL
A6-86	NULL
mutant	NULL
.	NULL

Columns	NULL
1	NULL
,	NULL
Rat-babe	NULL
;	NULL
columns	NULL
2	NULL
,	NULL
Rat-STP-C488	NULL
;	NULL
columns	NULL
3	NULL
,	NULL
Rat-TRAF2	NULL
A6-86	NULL
;	NULL
and	NULL
columns	NULL
4	NULL
,	NULL
Rat-STP-C488/TRAF2	NULL
A6-86	NULL
.	NULL

Cells	NULL
were	NULL
transfected	NULL
with	NULL
an	NULL
NF-	NULL
«	NULL
B-driven	NULL
luciferase	NULL
reporter	NULL
3XxB	NULL
plasmid	NULL
together	NULL
with	NULL
the	NULL
pGKBgal	NULL
plasmid	NULL
,	NULL
which	NULL
controlled	NULL
for	NULL
transfection	NULL
efficiency	NULL
.	NULL

Forty-cight	NULL
hours	NULL
after	NULL
transfection	NULL
,	NULL
cell	NULL
lysates	NULL
were	NULL
used	NULL
for	NULL
luciferase	NULL
and	NULL
B-galactosidase	NULL
assays	NULL
.	NULL

Where	NULL
indicated	NULL
,	NULL
Rat-1	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
10	NULL
ng	NULL
of	NULL
mouse	NULL
TNF-a	NULL
for	NULL
16	NULL
h.	NULL
Luciferase	NULL
activity	NULL
was	NULL
determined	NULL
and	NULL
normalized	NULL
on	NULL
the	NULL
basis	NULL
of	NULL
B-galactosidase	NULL
activities	NULL
.	NULL

The	NULL
fold	NULL
activation	NULL
expresses	NULL
the	NULL
normalized	NULL
luciferase	NULL
activity	NULL
relative	NULL
to	NULL
that	NULL
of	NULL
the	NULL
cells	NULL
transfected	NULL
with	NULL
vector	NULL
alone	NULL
(	NULL
panel	NULL
A	NULL
)	NULL
or	NULL
to	NULL
that	NULL
of	NULL
Rat-babe	NULL
cells	NULL
(	NULL
panel	NULL
B	NULL
)	NULL
.	NULL

Values	NULL
are	NULL
the	NULL
averages	NULL
of	NULL
three	NULL
independent	NULL
experiments	NULL
.	NULL

common	NULL
marmoset	NULL
lymphocytes	NULL
to	NULL
continuous	NULL
growth	NULL
and	NULL
of	NULL
inducing	NULL
lymphoma	NULL
in	NULL
common	NULL
marmosets	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
TRAF	NULL
binding	NULL
activity	NULL
of	NULL
STP-C488	NULL
is	NULL
not	NULL
essential	NULL
for	NULL
virus-induced	NULL
transformation	NULL
of	NULL
primary	NULL
marmoset	NULL
lymphocytes	NULL
in	NULL
vitro	NULL
and	NULL
in	NULL
vivo	NULL
.	NULL

Transformation	NULL
of	NULL
human	NULL
lymphocytes	NULL
by	NULL
recombinant	NULL
HVS	NULL
STP-C488	NULL
P	NULL
,	NULL
;	NULL
,	NULL
-R.	NULL
To	NULL
further	NULL
examine	NULL
the	NULL
role	NULL
of	NULL
STP-TRAF	NULL
interaction	NULL
in	NULL
transformation	NULL
,	NULL
HVS	NULL
STP-C488	NULL
P	NULL
;	NULL
,	NULL
-R	NULL
was	NULL
compared	NULL
with	NULL
wt	NULL
HVS	NULL
and	NULL
HVS	NULL
ASTP-SV40-SEAP	NULL
in	NULL
primary	NULL
human	NULL
T-lymphocyte	NULL
immortalization	NULL
assays	NULL
.	NULL

Equiva-	NULL
CELLULAR	NULL
TRAFs	NULL
IN	NULL
T-CELL	NULL
TRANSFORMATION	NULL
BY	NULL
HVS	NULL
STP	NULL
3917	NULL
lent	NULL
titers	NULL
of	NULL
HVS	NULL
STP-C488	NULL
P	NULL
;	NULL
,	NULL
-R	NULL
,	NULL
wt	NULL
HVS	NULL
,	NULL
and	NULL
HVS	NULL
ASTP-SV40-SEAP	NULL
were	NULL
used	NULL
to	NULL
infect	NULL
unstimulated	NULL
,	NULL
human	NULL
PBMCs	NULL
from	NULL
five	NULL
donors	NULL
.	NULL

HVS	NULL
transformed	NULL
the	NULL
primary	NULL
human	NULL
lymphocytes	NULL
from	NULL
three	NULL
of	NULL
the	NULL
five	NULL
donors	NULL
to	NULL
IL-2-independent	NULL
growth	NULL
within	NULL
about	NULL
2	NULL
months	NULL
postinfection	NULL
,	NULL
while	NULL
HVS	NULL
and	NULL
parental	NULL
HVSASTP-SV40-SEAP	NULL
failed	NULL
to	NULL
immortalize	NULL
primary	NULL
human	NULL
T	NULL
lymphocytes	NULL
to	NULL
IL-2-independent	NULL
growth	NULL
(	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

These	NULL
results	NULL
indicate	NULL
that	NULL
STP-TRAF	NULL
interaction	NULL
is	NULL
required	NULL
for	NULL
primary	NULL
human	NULL
lymphocyte	NULL
transformation	NULL
.	NULL

STP-C488	NULL
TRAF	NULL
binding	NULL
is	NULL
also	NULL
implicated	NULL
in	NULL
rodent	NULL
fibroblast	NULL
transformation	NULL
.	NULL

STP-C488	NULL
P	NULL
;	NULL
,	NULL
-R	NULL
mutant	NULL
,	NULL
which	NULL
fails	NULL
to	NULL
bind	NULL
to	NULL
TRAFs	NULL
,	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
defective	NULL
in	NULL
Rat-1	NULL
cell	NULL
transformation	NULL
(	NULL
26	NULL
)	NULL
.	NULL

To	NULL
further	NULL
investigate	NULL
the	NULL
specific	NULL
role	NULL
of	NULL
TRAF-mediated	NULL
signaling	NULL
in	NULL
STP	NULL
transformation	NULL
,	NULL
we	NULL
used	NULL
a	NULL
dominant-negative	NULL
mutant	NULL
of	NULL
TRAF2	NULL
,	NULL
TRAF2	NULL
A6-86	NULL
,	NULL
which	NULL
is	NULL
deleted	NULL
for	NULL
the	NULL
ring	NULL
finger	NULL
domain	NULL
.	NULL

The	NULL
TRAF2	NULL
ring	NULL
finger	NULL
domain	NULL
is	NULL
not	NULL
required	NULL
for	NULL
binding	NULL
to	NULL
TNFR2	NULL
,	NULL
CD40	NULL
,	NULL
or	NULL
LMP1	NULL
,	NULL
and	NULL
this	NULL
mutant	NULL
can	NULL
block	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
induced	NULL
by	NULL
LMP1	NULL
(	NULL
31	NULL
)	NULL
.	NULL

Rat-1	NULL
cells	NULL
stably	NULL
transfected	NULL
with	NULL
peDNA3-TRAF2	NULL
A6-86	NULL
or	NULL
pcDNA3	NULL
vector	NULL
were	NULL
derived	NULL
by	NULL
selection	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
500	NULL
wg	NULL
of	NULL
neomycin/ml	NULL
.	NULL

Rat-1	NULL
and	NULL
Rat-TRAF	NULL
A6-86	NULL
cells	NULL
were	NULL
then	NULL
transfected	NULL
with	NULL
a	NULL
pBabe-puro	NULL
vector	NULL
or	NULL
a	NULL
pBabe-STP-C488	NULL
vector	NULL
and	NULL
selected	NULL
with	NULL
5	NULL
wg	NULL
of	NULL
puromycin/ml	NULL
.	NULL

STP-C488	NULL
and	NULL
TRAF2	NULL
A6-86	NULL
expression	NULL
was	NULL
monitored	NULL
by	NULL
the	NULL
immunoblot	NULL
assay	NULL
with	NULL
anti-STP-C488	NULL
or	NULL
anti-Flag	NULL
antibody	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
growth	NULL
properties	NULL
of	NULL
Rat-babe	NULL
,	NULL
Rat-STP-C488	NULL
,	NULL
Rat-TRAFZ2	NULL
A6-86	NULL
,	NULL
and	NULL
Rat-STP-CA88/TRAF2	NULL
A6-86	NULL
cells	NULL
were	NULL
examined	NULL
to	NULL
investigate	NULL
whether	NULL
TRAF	NULL
A6-86	NULL
could	NULL
block	NULL
STP-C488-mediated	NULL
transformation	NULL
.	NULL

As	NULL
was	NULL
shown	NULL
previously	NULL
(	NULL
26	NULL
,	NULL
30	NULL
)	NULL
,	NULL
STP-C488	NULL
transformed	NULL
Rat-1	NULL
cells	NULL
,	NULL
resulting	NULL
in	NULL
focus	NULL
formation	NULL
(	NULL
Fig	NULL
.	NULL

6C	NULL
)	NULL
.	NULL

Foci	NULL
were	NULL
recognizable	NULL
even	NULL
before	NULL
cells	NULL
reached	NULL
confluence	NULL
.	NULL

The	NULL
expression	NULL
of	NULL
TRAF2	NULL
A6-86	NULL
drastically	NULL
suppressed	NULL
the	NULL
transformation	NULL
of	NULL
Rat-1	NULL
cells	NULL
by	NULL
STP-C488	NULL
(	NULL
Fig	NULL
.	NULL

6D	NULL
)	NULL
.	NULL

The	NULL
number	NULL
of	NULL
foci	NULL
observed	NULL
for	NULL
Rat-STP-C488	NULL
cells	NULL
was	NULL
over	NULL
1,000	NULL
per	NULL
10°	NULL
cells	NULL
,	NULL
whereas	NULL
Rat-STP-C488/TRAF	NULL
A6-86	NULL
cells	NULL
grew	NULL
in	NULL
flat	NULL
monolayers	NULL
and	NULL
formed	NULL
less	NULL
than	NULL
40	NULL
foci	NULL
per	NULL
10°	NULL
cells	NULL
.	NULL

These	NULL
results	NULL
demonstrate	NULL
that	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
dominant-negative	NULL
TRAF2	NULL
A6-86	NULL
mutant	NULL
blocks	NULL
Rat-1	NULL
cell	NULL
transformation	NULL
by	NULL
STP-C488	NULL
.	NULL

Rat-babe	NULL
,	NULL
Rat-STP-C488	NULL
,	NULL
Rat-TRAF2	NULL
A6-86	NULL
,	NULL
and	NULL
Rat-STP-CA488/TRAF2	NULL
A6-86	NULL
cells	NULL
were	NULL
also	NULL
used	NULL
to	NULL
measure	NULL
the	NULL
level	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
activity	NULL
.	NULL

Cells	NULL
were	NULL
treated	NULL
with	NULL
TNF-a	NULL
as	NULL
controls	NULL
.	NULL

TNF-a	NULL
treatment	NULL
or	NULL
STP-C488	NULL
expression	NULL
induced	NULL
NF-kB	NULL
activity	NULL
in	NULL
Rat-1	NULL
cells	NULL
approximately	NULL
fourfold	NULL
more	NULL
than	NULL
that	NULL
in	NULL
control	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
)	NULL
.	NULL

However	NULL
,	NULL
TNF-	NULL
«	NULL
treatment	NULL
did	NULL
not	NULL
further	NULL
induce	NULL
NF-KB	NULL
activity	NULL
in	NULL
Rat-STP-C488	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
dominant-negative	NULL
mutant	NULL
TRAF2	NULL
A6-86	NULL
abolished	NULL
NF-kB	NULL
activation	NULL
by	NULL
STP-C488	NULL
or	NULL
TNF-a	NULL
treatment	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
)	NULL
.	NULL

These	NULL
results	NULL
indicate	NULL
that	NULL
TRAF	NULL
TABLE	NULL
1	NULL
.	NULL

In	NULL
vitro	NULL
and	NULL
in	NULL
vivo	NULL
oncogenicity	NULL
of	NULL
HVS	NULL
STP-C488	NULL
P	NULL
;	NULL
p-	NULL
>	NULL
R	NULL
No	NULL
.	NULL

of	NULL
positive	NULL
samples	NULL
or	NULL
animals/no	NULL
.	NULL

tested	NULL
Virus	NULL
Immortalization	NULL
of	NULL
:	NULL
Survival	NULL
.	NULL

In	NULL
vivo	NULL
.	NULL

of	NULL
d	NULL
Primary	NULL
common	NULL
marmoset	NULL
Primary	NULL
human	NULL
T	NULL
Virus	NULL
recovery	NULL
``	NULL
lymphoma	NULL
(	NULL
no	NULL
.	NULL

of	NULL
days	NULL
)	NULL
T	NULL
lymphocytes	NULL
lymphocytes	NULL
None	NULL
0/9	NULL
HVS	NULL
C488	NULL
9/9	NULL
3/5	NULL
2/2	NULL
2/2	NULL
19	NULL
,	NULL
20	NULL
HVS	NULL
ASTP-SV40-SEAP	NULL
0/9	NULL
0/5	NULL
2/2	NULL
0/2	NULL
>	NULL
370	NULL
HVS	NULL
STP-C488	NULL
P	NULL
;	NULL
p-R	NULL
9/9	NULL
0/5	NULL
2/2	NULL
2/2	NULL
20	NULL
``	NULL
Virus	NULL
was	NULL
recovered	NULL
from	NULL
PBMCs	NULL
of	NULL
two	NULL
infected	NULL
marmosets	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
14	NULL
)	NULL
.	NULL

3918	NULL
LEE	NULL
ET	NULL
AL	NULL
.	NULL

J.	NULL
Virou	NULL
.	NULL

mediated	NULL
signaling	NULL
is	NULL
important	NULL
for	NULL
STP-C488-induced	NULL
transformation	NULL
and	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
in	NULL
Rat-1	NULL
cells	NULL
.	NULL

DISCUSSION	NULL
In	NULL
this	NULL
report	NULL
we	NULL
demonstrate	NULL
that	NULL
STP	NULL
of	NULL
HVS	NULL
subgroups	NULL
A	NULL
and	NULL
C	NULL
can	NULL
associate	NULL
with	NULL
TRAFs	NULL
.	NULL

Furthermore	NULL
,	NULL
STP-C488	NULL
activates	NULL
NF-kB	NULL
and	NULL
this	NULL
activation	NULL
is	NULL
dependent	NULL
on	NULL
the	NULL
same	NULL
STP-C488	NULL
residues	NULL
that	NULL
are	NULL
required	NULL
for	NULL
TRAF	NULL
association	NULL
.	NULL

Moreover	NULL
,	NULL
an	NULL
HVS	NULL
STP-C488	NULL
P	NULL
;	NULL
,	NULL
-	NULL
>	NULL
R	NULL
mutation	NULL
that	NULL
codes	NULL
for	NULL
an	NULL
STP-C488	NULL
mutant	NULL
,	NULL
which	NULL
does	NULL
not	NULL
interact	NULL
with	NULL
TRAF	NULL
,	NULL
can	NULL
not	NULL
transform	NULL
primary	NULL
human	NULL
T	NULL
lymphocytes	NULL
or	NULL
Rat-1	NULL
cells	NULL
in	NULL
vitro	NULL
.	NULL

Thus	NULL
,	NULL
TRAF	NULL
interaction	NULL
is	NULL
implicated	NULL
in	NULL
HVS	NULL
STP-C488	NULL
transforming	NULL
activity	NULL
.	NULL

However	NULL
,	NULL
HVS	NULL
STP-C488	NULL
P	NULL
;	NULL
,	NULL
-R	NULL
is	NULL
able	NULL
to	NULL
transform	NULL
marmoset	NULL
T	NULL
lymphocytes	NULL
and	NULL
induce	NULL
malignant	NULL
lymphoma	NULL
in	NULL
marmosets	NULL
.	NULL

TRAF	NULL
binding	NULL
is	NULL
therefore	NULL
only	NULL
one	NULL
component	NULL
of	NULL
STP-C488	NULL
transforming	NULL
activity	NULL
.	NULL

The	NULL
observation	NULL
that	NULL
STP	NULL
interaction	NULL
with	NULL
TRAF	NULL
is	NULL
required	NULL
for	NULL
human	NULL
T-lymphocyte	NULL
and	NULL
Rat-1-cell	NULL
transformation	NULL
but	NULL
not	NULL
for	NULL
marmoset	NULL
T-lymphocyte	NULL
transformation	NULL
indicates	NULL
that	NULL
TRAF	NULL
interaction	NULL
is	NULL
important	NULL
for	NULL
transformation	NULL
in	NULL
restricted	NULL
genetic	NULL
or	NULL
developmental	NULL
backgrounds	NULL
.	NULL

This	NULL
is	NULL
not	NULL
surprising	NULL
,	NULL
since	NULL
HVS	NULL
has	NULL
a	NULL
number	NULL
of	NULL
genes	NULL
which	NULL
may	NULL
contribute	NULL
to	NULL
cell	NULL
growth	NULL
transformation	NULL
,	NULL
including	NULL
those	NULL
encoding	NULL
tip	NULL
,	NULL
v-cyclin	NULL
,	NULL
vIL-17	NULL
,	NULL
orf14	NULL
superantigen	NULL
homolog	NULL
,	NULL
v€D59	NULL
,	NULL
vbel-2	NULL
,	NULL
vFLIP	NULL
,	NULL
and	NULL
vIL-8	NULL
receptor	NULL
,	NULL
as	NULL
well	NULL
as	NULL
the	NULL
rest	NULL
of	NULL
the	NULL
STP	NULL
open	NULL
reading	NULL
frame	NULL
(	NULL
1	NULL
,	NULL
29	NULL
,	NULL
42	NULL
,	NULL
44	NULL
,	NULL
50	NULL
,	NULL
52	NULL
,	NULL
53	NULL
)	NULL
.	NULL

Since	NULL
many	NULL
of	NULL
these	NULL
genes	NULL
are	NULL
likely	NULL
expressed	NULL
in	NULL
transformed	NULL
marmoset	NULL
T	NULL
lymphocytes	NULL
(	NULL
18	NULL
)	NULL
,	NULL
STP-TRAF-mediated	NULL
signaling	NULL
may	NULL
be	NULL
less	NULL
important	NULL
in	NULL
this	NULL
cell	NULL
type	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
HVS	NULL
is	NULL
tightly	NULL
latent	NULL
in	NULL
transformed	NULL
human	NULL
T	NULL
lymphocytes	NULL
,	NULL
where	NULL
the	NULL
single	NULL
bicistronic	NULL
STP	NULL
and	NULL
tip	NULL
transcript	NULL
has	NULL
been	NULL
detected	NULL
(	NULL
18	NULL
)	NULL
.	NULL

Rat-l-cell	NULL
transformation	NULL
requires	NULL
only	NULL
STP-C488	NULL
.	NULL

Thus	NULL
,	NULL
HVS	NULL
may	NULL
be	NULL
considerably	NULL
less	NULL
dependent	NULL
on	NULL
STP	NULL
for	NULL
marmoset	NULL
lymphocyte	NULL
transformation	NULL
because	NULL
of	NULL
other	NULL
viral	NULL
genes	NULL
expressed	NULL
in	NULL
these	NULL
cells	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
STP-C488	NULL
binding	NULL
to	NULL
cellular	NULL
Ras	NULL
is	NULL
also	NULL
important	NULL
for	NULL
Rat-1	NULL
cell	NULL
transformation	NULL
(	NULL
25	NULL
)	NULL
,	NULL
and	NULL
the	NULL
role	NULL
of	NULL
Ras	NULL
interaction	NULL
in	NULL
marmoset	NULL
and	NULL
human	NULL
lymphocyte	NULL
transformation	NULL
remains	NULL
to	NULL
be	NULL
investigated	NULL
.	NULL

HVS	NULL
strains	NULL
are	NULL
classified	NULL
into	NULL
three	NULL
subgroups	NULL
(	NULL
subgroups	NULL
A	NULL
,	NULL
B	NULL
,	NULL
and	NULL
C	NULL
)	NULL
based	NULL
on	NULL
sequence	NULL
divergence	NULL
in	NULL
the	NULL
STP	NULL
and	NULL
fip	NULL
genes	NULL
(	NULL
5	NULL
,	NULL
36	NULL
)	NULL
.	NULL

Subgroups	NULL
A	NULL
and	NULL
C	NULL
are	NULL
highly	NULL
oncogenic	NULL
and	NULL
are	NULL
able	NULL
to	NULL
immortalize	NULL
common	NULL
marmoset	NULL
T	NULL
lymphocytes	NULL
,	NULL
induc-	NULL
FIG	NULL
.	NULL

6	NULL
.	NULL

Inhibition	NULL
of	NULL
transformation	NULL
of	NULL
STP-C488	NULL
by	NULL
the	NULL
dominant-negative	NULL
TRAF2	NULL
mutant	NULL
.	NULL

Rat-1	NULL
fibroblast	NULL
cells	NULL
were	NULL
plated	NULL
at	NULL
10°	NULL
cells	NULL
per	NULL
100-mm-diameter	NULL
tissue	NULL
culture	NULL
dishes	NULL
.	NULL

After	NULL
14	NULL
days	NULL
'	NULL
incubation	NULL
,	NULL
cells	NULL
were	NULL
photographed	NULL
to	NULL
show	NULL
foci	NULL
of	NULL
transformed	NULL
cells	NULL
at	NULL
magnification	NULL
of	NULL
X100	NULL
(	NULL
bottom	NULL
)	NULL
and	NULL
after	NULL
staining	NULL
with	NULL
methylene	NULL
blue	NULL
(	NULL
top	NULL
)	NULL
.	NULL

A	NULL
,	NULL
Rat-babe	NULL
;	NULL
B	NULL
,	NULL
Rat-TRAF2	NULL
A6-86	NULL
;	NULL
C	NULL
,	NULL
Rat-STP-C488	NULL
;	NULL
and	NULL
D	NULL
,	NULL
Rat-STP-C488/TRAF2	NULL
A6-86	NULL
.	NULL

ing	NULL
transformation	NULL
to	NULL
growth	NULL
in	NULL
an	NULL
IL-2-independent	NULL
manner	NULL
in	NULL
vitro	NULL
,	NULL
while	NULL
subgroup	NULL
B	NULL
does	NULL
not	NULL
have	NULL
these	NULL
properties	NULL
(	NULL
13	NULL
,	NULL
37	NULL
)	NULL
.	NULL

Subgroup	NULL
C	NULL
strains	NULL
are	NULL
in	NULL
addition	NULL
capable	NULL
of	NULL
immortalizing	NULL
human	NULL
,	NULL
rabbit	NULL
,	NULL
and	NULL
rhesus	NULL
monkey	NULL
lymphocytes	NULL
into	NULL
continuously	NULL
proliferating	NULL
T-cell	NULL
lines	NULL
(	NULL
1	NULL
,	NULL
3	NULL
)	NULL
.	NULL

All	NULL
STP-A	NULL
and	NULL
STP-C	NULL
isolates	NULL
which	NULL
have	NULL
been	NULL
sequenced	NULL
so	NULL
far	NULL
appear	NULL
to	NULL
be	NULL
similar	NULL
around	NULL
the	NULL
TRAF-binding	NULL
sites	NULL
that	NULL
have	NULL
been	NULL
revealed	NULL
by	NULL
the	NULL
biochemical	NULL
and	NULL
genetic	NULL
analyses	NULL
described	NULL
here	NULL
(	NULL
18	NULL
,	NULL
34	NULL
)	NULL
.	NULL

These	NULL
experiments	NULL
show	NULL
that	NULL
oncogenes	NULL
from	NULL
the	NULL
transforming	NULL
gamma	NULL
herpesviruses	NULL
EBV	NULL
and	NULL
HVS	NULL
employ	NULL
TRAF	NULL
as	NULL
a	NULL
common	NULL
cellular	NULL
factor	NULL
for	NULL
their	NULL
activities	NULL
.	NULL

Previous	NULL
experiments	NULL
with	NULL
EBV	NULL
LMP1	NULL
point	NULL
up	NULL
the	NULL
importance	NULL
of	NULL
both	NULL
aggregation	NULL
and	NULL
TRAF	NULL
binding	NULL
in	NULL
signaling	NULL
(	NULL
24	NULL
,	NULL
38	NULL
)	NULL
.	NULL

STP-C488	NULL
can	NULL
also	NULL
oligomerize	NULL
through	NULL
its	NULL
collagen-like	NULL
motif	NULL
(	NULL
unpublished	NULL
re-sults	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
HVS	NULL
STP-C488	NULL
and	NULL
EBV	NULL
LMP1	NULL
may	NULL
mimic	NULL
a	NULL
ligand-independent	NULL
constitutively	NULL
active	NULL
receptor	NULL
.	NULL

While	NULL
STPs	NULL
of	NULL
HVS	NULL
subgroups	NULL
A	NULL
and	NULL
C	NULL
bind	NULL
to	NULL
TRAF	NULL
1	NULL
,	NULL
2	NULL
,	NULL
and	NULL
3	NULL
,	NULL
only	NULL
STP-C488	NULL
interaction	NULL
with	NULL
TRAF	NULL
appears	NULL
to	NULL
activate	NULL
NF-kB	NULL
activity	NULL
.	NULL

This	NULL
may	NULL
explain	NULL
why	NULL
STP-C488	NULL
is	NULL
considerably	NULL
more	NULL
potent	NULL
in	NULL
Rat-1-cell	NULL
transformation	NULL
than	NULL
STP-All	NULL
(	NULL
30	NULL
)	NULL
.	NULL

On	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
STP-A1l	NULL
may	NULL
use	NULL
TRAF	NULL
interaction	NULL
for	NULL
the	NULL
activation	NULL
of	NULL
downstream	NULL
effectors	NULL
other	NULL
than	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
e.g	NULL
.	NULL

,	NULL
activation	NULL
of	NULL
stress-activated	NULL
protein	NULL
kinase	NULL
or	NULL
inhibitors	NULL
of	NULL
apoptosis	NULL
(	NULL
41	NULL
,	NULL
51	NULL
,	NULL
54	NULL
)	NULL
.	NULL

Further	NULL
studies	NULL
are	NULL
needed	NULL
to	NULL
elucidate	NULL
the	NULL
detailed	NULL
mechanisms	NULL
of	NULL
HVS	NULL
STP-TRAF-mediated	NULL
signal	NULL
transduction	NULL
.	NULL

ACKNOWLEDGMENTS	NULL
We	NULL
thank	NULL
R.	NULL
Desrosiers	NULL
,	NULL
K.	NULL
Williams	NULL
,	NULL
L.	NULL
Alexander	NULL
,	NULL
and	NULL
R.	NULL
Means	NULL
for	NULL
critical	NULL
reading	NULL
of	NULL
the	NULL
manuscript	NULL
and	NULL
G.	NULL
Mosialos	NULL
for	NULL
providing	NULL
reagents	NULL
.	NULL

We	NULL
also	NULL
thank	NULL
Kristen	NULL
Toohey	NULL
for	NULL
photography	NULL
support	NULL
.	NULL

This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
U.S.	NULL
Public	NULL
Health	NULL
Service	NULL
grants	NULL
CA31363	NULL
and	NULL
RRO0168	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Abuja	NULL
,	NULL
S.	NULL
K.	NULL
,	NULL
and	NULL
P.	NULL
M.	NULL
Murphy	NULL
.	NULL

1996	NULL
.	NULL

Molecular	NULL
piracy	NULL
of	NULL
mammalian	NULL
interleukin-8	NULL
receptor	NULL
type	NULL
B	NULL
by	NULL
herpesvirus	NULL
saimiri	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268	NULL
:	NULL
20691-20694	NULL
.	NULL

2	NULL
.	NULL

Alexander	NULL
,	NULL
L.	NULL
,	NULL
Z	NULL
.	NULL

Du	NULL
,	NULL
M.	NULL
Rosenzweig	NULL
,	NULL
J.	NULL
U.	NULL
Jung	NULL
,	NULL
and	NULL
R.	NULL
C.	NULL
Desrosiers	NULL
.	NULL

1997	NULL
.	NULL

A	NULL
role	NULL
for	NULL
natural	NULL
simian	NULL
immunodeficiency	NULL
virus	NULL
and	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
Nef	NULL
alleles	NULL
in	NULL
lymphocyte	NULL
activation	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

71:6094-6099	NULL
.	NULL

3	NULL
.	NULL

Bentler	NULL
,	NULL
B.	NULL
,	NULL
and	NULL
A.	NULL
Cerami	NULL
.	NULL

1988	NULL
.	NULL

Tumor	NULL
necrosis	NULL
,	NULL
cachexia	NULL
,	NULL
shock	NULL
and	NULL
inflammation	NULL
:	NULL
a	NULL
common	NULL
mediator	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Biochem	NULL
.	NULL

57:505-518.	NULL
voL	NULL
.	NULL

73	NULL
,	NULL
1999	NULL
4	NULL
.	NULL

10	NULL
.	NULL

11	NULL
.	NULL

12	NULL
.	NULL

13	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

Biesinger	NULL
,	NULL
B.	NULL
,	NULL
I.	NULL
Miiller-Fleckenstein	NULL
,	NULL
B.	NULL
Simmer	NULL
,	NULL
G.	NULL
Lang	NULL
,	NULL
S.	NULL
Wittmann	NULL
,	NULL
E.	NULL
Platzer	NULL
,	NULL
R.	NULL
C.	NULL
Desrosiers	NULL
,	NULL
and	NULL
B.	NULL
Fleckenstein	NULL
.	NULL

1992	NULL
.	NULL

Stable	NULL
growth	NULL
transformation	NULL
of	NULL
human	NULL
T	NULL
lymphocytes	NULL
by	NULL
herpesvirus	NULL
saimiri	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
89:3116-3119.	NULL
.	NULL

Biesinger	NULL
,	NULL
B.	NULL
,	NULL
J.	NULL
J.	NULL
Trimble	NULL
,	NULL
R.	NULL
C.	NULL
Desrosiers	NULL
,	NULL
and	NULL
B.	NULL
Fleckenstein	NULL
.	NULL

1990	NULL
.	NULL

The	NULL
divergence	NULL
between	NULL
two	NULL
oncogenic	NULL
herpesvirus	NULL
saimiri	NULL
strains	NULL
in	NULL
a	NULL
genomic	NULL
region	NULL
related	NULL
to	NULL
the	NULL
transforming	NULL
phenotype	NULL
.	NULL

Virology	NULL
176:505-514.	NULL
.	NULL

Broker	NULL
,	NULL
B.	NULL
M.	NULL
,	NULL
A.	NULL
Y.	NULL
Tsygankov	NULL
,	NULL
I	NULL
Muller-Fleckenstein	NULL
,	NULL
A.	NULL
H.	NULL
Guse	NULL
,	NULL
N.	NULL
A.	NULL
Chitaey	NULL
,	NULL
B.	NULL
Biesinger	NULL
,	NULL
B.	NULL
Fleckenstein	NULL
,	NULL
and	NULL
F.	NULL
Emmrich	NULL
.	NULL

1993	NULL
.	NULL

Immortalization	NULL
of	NULL
human	NULL
T	NULL
cell	NULL
clones	NULL
by	NULL
Herpesvirus	NULL
seimiri	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

151:1184-1192.	NULL
.	NULL

Cheng	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1996	NULL
.	NULL

TANK	NULL
,	NULL
a	NULL
co-inducer	NULL
with	NULL
TRAF2	NULL
of	NULL
TNF-	NULL
and	NULL
CD40L-mediated	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

10:963-973.	NULL
.	NULL

Cheng	NULL
,	NULL
G.	NULL
,	NULL
A.	NULL
M.	NULL
Cleary	NULL
,	NULL
Z.-S.	NULL
Ye	NULL
,	NULL
D.	NULL
I.	NULL
Hong	NULL
,	NULL
S.	NULL
Lederman	NULL
,	NULL
and	NULL
D.	NULL
Balti-	NULL
more	NULL
.	NULL

1995	NULL
.	NULL

Involvement	NULL
of	NULL
CRAF1	NULL
,	NULL
a	NULL
relative	NULL
of	NULL
TRAF	NULL
,	NULL
in	NULL
CD40	NULL
signaling	NULL
.	NULL

Science	NULL
267:1494-1497.	NULL
.	NULL

Desrosiers	NULL
,	NULL
R.	NULL
C.	NULL
,	NULL
A.	NULL
Bakker	NULL
,	NULL
J.	NULL
Kamine	NULL
,	NULL
L.	NULL
A.	NULL
Falk	NULL
,	NULL
R.	NULL
D.	NULL
Hunt	NULL
,	NULL
and	NULL
N.	NULL
W.	NULL
King	NULL
.	NULL

1985	NULL
.	NULL

A	NULL
region	NULL
of	NULL
the	NULL
herpesvirus	NULL
saimiri	NULL
genome	NULL
required	NULL
for	NULL
oncogenicity	NULL
.	NULL

Science	NULL
228:184-187	NULL
.	NULL

Desrosiers	NULL
,	NULL
R.	NULL
C.	NULL
,	NULL
R.	NULL
L.	NULL
Burghoff	NULL
,	NULL
A.	NULL
Bakker	NULL
,	NULL
and	NULL
J.	NULL
Kamine	NULL
.	NULL

1984	NULL
.	NULL

Construction	NULL
of	NULL
replication-competent	NULL
herpesvirus	NULL
saimiri	NULL
deletion	NULL
mutants	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

49:343-348	NULL
.	NULL

Desrosiers	NULL
,	NULL
R.	NULL
C.	NULL
,	NULL
and	NULL
L.	NULL
A.	NULL
Falk	NULL
,	NULL
1982	NULL
.	NULL

Herpesvirus	NULL
saimiri	NULL
strain	NULL
variability	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

43:352-356	NULL
.	NULL

Desrosiers	NULL
,	NULL
R.	NULL
C.	NULL
,	NULL
D.	NULL
Silva	NULL
,	NULL
L.	NULL
M.	NULL
Waldron	NULL
,	NULL
and	NULL
N.	NULL
L.	NULL
Letvin	NULL
.	NULL

1986	NULL
.	NULL

Nononcogenic	NULL
deletion	NULL
mutants	NULL
of	NULL
herpesvirus	NULL
saimiri	NULL
are	NULL
defective	NULL
for	NULL
in	NULL
vitro	NULL
immortalization	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

57:701-705	NULL
.	NULL

Devergne	NULL
,	NULL
O.	NULL
,	NULL
E.	NULL
C.	NULL
McFarland	NULL
,	NULL
G.	NULL
Mosialos	NULL
,	NULL
K.	NULL
M.	NULL
Izumi	NULL
,	NULL
C.	NULL
F.	NULL
Ware	NULL
,	NULL
and	NULL
E.	NULL
Kieff	NULL
.	NULL

1998	NULL
.	NULL

Role	NULL
of	NULL
the	NULL
TRAF	NULL
binding	NULL
site	NULL
and	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
in	NULL
Epstein-Barr	NULL
virus	NULL
latent	NULL
membrane	NULL
protein	NULL
1-induced	NULL
cell	NULL
gene	NULL
expression	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

72:7900-7908	NULL
.	NULL

Duboise	NULL
,	NULL
S.	NULL
M.	NULL
,	NULL
J.	NULL
Guo	NULL
,	NULL
S.	NULL
Czajak	NULL
,	NULL
R.	NULL
C.	NULL
Desrosiers	NULL
,	NULL
and	NULL
J.	NULL
U.	NULL
Jung	NULL
.	NULL

1998	NULL
.	NULL

STP	NULL
and	NULL
tip	NULL
are	NULL
essential	NULL
for	NULL
herpesvirus	NULL
saimiri	NULL
oncogenicity	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

72:1308-1313	NULL
.	NULL

Duboise	NULL
,	NULL
S.	NULL
M.	NULL
,	NULL
J.	NULL
Guo	NULL
,	NULL
R.	NULL
C.	NULL
Desrosiers	NULL
,	NULL
and	NULL
J.	NULL
U.	NULL
Jung	NULL
.	NULL

1996	NULL
.	NULL

Use	NULL
of	NULL
virion	NULL
DNA	NULL
as	NULL
a	NULL
cloning	NULL
vector	NULL
for	NULL
the	NULL
construction	NULL
of	NULL
mutant	NULL
and	NULL
recombinant	NULL
herpesviruses	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
93:11389-11394	NULL
.	NULL

Du	NULL
,	NULL
Z.	NULL
,	NULL
D.	NULL
A.	NULL
Regier	NULL
,	NULL
and	NULL
R.	NULL
C.	NULL
Desrosiers	NULL
.	NULL

1995	NULL
.	NULL

Improved	NULL
recombinant	NULL
PCR	NULL
mutagenesis	NULL
procedure	NULL
that	NULL
uses	NULL
alkaline-denatured	NULL
plasmid	NULL
template	NULL
.	NULL

Bio-Techniques	NULL
18:376-378	NULL
.	NULL

Falk	NULL
,	NULL
L.	NULL
,	NULL
L.	NULL
Wolfe	NULL
,	NULL
and	NULL
F.	NULL
Deinhardt	NULL
.	NULL

1972	NULL
.	NULL

Isolation	NULL
of	NULL
herpesvirus	NULL
saimiri	NULL
from	NULL
blood	NULL
of	NULL
squirrel	NULL
monkeys	NULL
(	NULL
Saimiri	NULL
sciureus	NULL
)	NULL
.	NULL

J.	NULL
Natl	NULL
.	NULL

Cancer	NULL
Inst	NULL
.	NULL

48:1499-1505	NULL
.	NULL

Fickenscher	NULL
,	NULL
H.	NULL
,	NULL
B.	NULL
Biesinger	NULL
,	NULL
A.	NULL
Knappe	NULL
,	NULL
S.	NULL
Wittmann	NULL
,	NULL
and	NULL
B.	NULL
Fleckenstein	NULL
.	NULL

1996	NULL
.	NULL

Regulation	NULL
of	NULL
the	NULL
herpesvirus	NULL
saimiri	NULL
oncogene	NULL
sipC	NULL
,	NULL
similar	NULL
to	NULL
that	NULL
of	NULL
T-cell	NULL
activation	NULL
genes	NULL
,	NULL
in	NULL
growth-transformed	NULL
human	NULL
T	NULL
lymphocytes	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

70:6012-6019	NULL
.	NULL

Fleckenstein	NULL
,	NULL
B.	NULL
,	NULL
and	NULL
R.	NULL
C.	NULL
Desrosiers	NULL
.	NULL

1982	NULL
.	NULL

Herpesvirus	NULL
saimiri	NULL
and	NULL
herpesvirus	NULL
ateles	NULL
,	NULL
p.	NULL
253-332	NULL
.	NULL

In	NULL
B.	NULL
Roizman	NULL
(	NULL
ed	NULL
.	NULL
)	NULL

,	NULL
The	NULL
herpesviruses	NULL
,	NULL
vol	NULL
.	NULL

1	NULL
.	NULL

Plenum	NULL
Publishing	NULL
Corporation	NULL
,	NULL
New	NULL
York	NULL
,	NULL
N.Y.	NULL
Franken	NULL
,	NULL
M.	NULL
,	NULL
O.	NULL
Devergne	NULL
,	NULL
M.	NULL
Rosenzweig	NULL
,	NULL
B.	NULL
Annis	NULL
,	NULL
E.	NULL
Kieff	NULL
,	NULL
and	NULL
F.	NULL
Wang	NULL
.	NULL

1996	NULL
.	NULL

Comparative	NULL
analysis	NULL
identifies	NULL
conserved	NULL
tumor	NULL
necrosis	NULL
factor	NULL
receptor-associated	NULL
factor	NULL
3	NULL
binding	NULL
sites	NULL
in	NULL
the	NULL
human	NULL
and	NULL
simian	NULL
Epstein-Barr	NULL
virus	NULL
oncogene	NULL
LMP1	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

70:7819-7826	NULL
.	NULL

Gedrich	NULL
,	NULL
R.	NULL
W.	NULL
,	NULL
M.	NULL
C.	NULL
Gilfillan	NULL
,	NULL
C.	NULL
S.	NULL
Duckett	NULL
,	NULL
J.	NULL
L.	NULL
Van	NULL
Dongen	NULL
,	NULL
and	NULL
C.	NULL
B.	NULL
Thompson	NULL
.	NULL

1996	NULL
.	NULL

CD30	NULL
contains	NULL
two	NULL
binding	NULL
sites	NULL
with	NULL
different	NULL
specificities	NULL
for	NULL
members	NULL
of	NULL
the	NULL
tumor	NULL
necrosis	NULL
factor	NULL
receptor-associated	NULL
factor	NULL
family	NULL
of	NULL
signal	NULL
transducing	NULL
proteins	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

271:12852-12858	NULL
.	NULL

Goeddel	NULL
,	NULL
D.	NULL
V.	NULL
,	NULL
B	NULL
.	NULL

B.	NULL
Aggarwal	NULL
,	NULL
P.	NULL
W.	NULL
Gray	NULL
,	NULL
D.	NULL
W.	NULL
Leung	NULL
,	NULL
G.	NULL
E.	NULL
Nedwin	NULL
,	NULL
G.	NULL
E.	NULL
Palladino	NULL
,	NULL
J.	NULL
S.	NULL
Patton	NULL
,	NULL
D.	NULL
Pennica	NULL
,	NULL
H.	NULL
M.	NULL
Shepard	NULL
,	NULL
B.	NULL
J.	NULL
Sugarman	NULL
,	NULL
and	NULL
G.	NULL
H.	NULL
W.	NULL
Wong	NULL
.	NULL

1986	NULL
.	NULL

Tumor	NULL
necrosis	NULL
factors	NULL
:	NULL
gene	NULL
structure	NULL
and	NULL
biological	NULL
activities	NULL
.	NULL

Cold	NULL
Spring	NULL
Harbor	NULL
Symp	NULL
.	NULL

Quant	NULL
.	NULL

Biol	NULL
.	NULL

51:597-609	NULL
.	NULL

Hu	NULL
,	NULL
H.	NULL
M.	NULL
,	NULL
K.	NULL
O'Rourke	NULL
,	NULL
M.	NULL
S.	NULL
Boguski	NULL
,	NULL
and	NULL
V.	NULL
M.	NULL
Dixit	NULL
.	NULL

1994	NULL
.	NULL

A	NULL
novel	NULL
RING	NULL
finger	NULL
protein	NULL
interacts	NULL
with	NULL
the	NULL
cytoplasmic	NULL
domain	NULL
of	NULL
CD40	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

269:30069-30076	NULL
.	NULL

Izumi	NULL
,	NULL
K.	NULL
M.	NULL
,	NULL
K.	NULL
M.	NULL
Kaye	NULL
,	NULL
and	NULL
E.	NULL
D.	NULL
Kieff	NULL
.	NULL

1997	NULL
.	NULL

The	NULL
Epstein-Barr	NULL
virus	NULL
LMP1	NULL
amino	NULL
acid	NULL
sequence	NULL
that	NULL
engages	NULL
tumor	NULL
necrosis	NULL
factor	NULL
receptor	NULL
associated	NULL
factors	NULL
is	NULL
critical	NULL
for	NULL
primary	NULL
B	NULL
lymphocyte	NULL
growth	NULL
transformation	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
94:1447-1452	NULL
.	NULL

Jung	NULL
,	NULL
J.	NULL
U.	NULL
,	NULL
and	NULL
R.	NULL
C.	NULL
Desrosiers	NULL
.	NULL

1995	NULL
.	NULL

Association	NULL
of	NULL
the	NULL
viral	NULL
oncoprotein	NULL
STP-C488	NULL
with	NULL
cellular	NULL
ras	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

15:6506-6512	NULL
.	NULL

Jung	NULL
,	NULL
J.	NULL
U.	NULL
,	NULL
and	NULL
R.	NULL
C.	NULL
Desrosiers	NULL
.	NULL

1994	NULL
.	NULL

Distinct	NULL
functional	NULL
domains	NULL
of	NULL
STP-C488	NULL
of	NULL
herpesvirus	NULL
saimiri	NULL
.	NULL

Virology	NULL
204:751-758	NULL
.	NULL

Jung	NULL
,	NULL
J.	NULL
U.	NULL
,	NULL
and	NULL
R.	NULL
C.	NULL
Desrosiers	NULL
.	NULL

1994	NULL
.	NULL

Herpesvirus	NULL
saimiri	NULL
and	NULL
ateles	NULL
,	NULL
p.	NULL
614-622	NULL
.	NULL

In	NULL
R.	NULL
Webster	NULL
and	NULL
A.	NULL
Granoff	NULL
(	NULL
ed	NULL
.	NULL
)	NULL

,	NULL
Encyclopedia	NULL
of	NULL
virology	NULL
.	NULL

Saunders	NULL
Scientific	NULL
Publications	NULL
,	NULL
Inc.	NULL
,	NULL
Philadelphia	NULL
,	NULL
Pa.	NULL
Jung	NULL
,	NULL
J.	NULL
U.	NULL
,	NULL
and	NULL
R.	NULL
C.	NULL
Desrosiers	NULL
.	NULL

1991	NULL
.	NULL

Identification	NULL
and	NULL
characterization	NULL
of	NULL
the	NULL
herpesvirus	NULL
saimiri	NULL
oncoprotein	NULL
STP-C488	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

65:6953-6960	NULL
.	NULL

Jung	NULL
,	NULL
J.	NULL
U.	NULL
,	NULL
M.	NULL
Stiiger	NULL
,	NULL
and	NULL
R.	NULL
C.	NULL
Desrosiers	NULL
.	NULL

1994	NULL
.	NULL

Virus-encoded	NULL
cyclin	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14:7235-7244	NULL
.	NULL

Jung	NULL
,	NULL
J.	NULL
U.	NULL
,	NULL
J.	NULL
J.	NULL
Trimble	NULL
,	NULL
N.	NULL
W.	NULL
King	NULL
,	NULL
B.	NULL
Biesinger	NULL
,	NULL
B.	NULL
W.	NULL
Fleckenstein	NULL
,	NULL
and	NULL
R.	NULL
C.	NULL
Desrosiers	NULL
.	NULL

1991	NULL
.	NULL

Identification	NULL
of	NULL
transforming	NULL
genes	NULL
of	NULL
subgroup	NULL
A	NULL
CELLULAR	NULL
TRAFs	NULL
IN	NULL
T-CELL	NULL
TRANSFORMATION	NULL
BY	NULL
HVS	NULL
STP	NULL
31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

44	NULL
.	NULL

45	NULL
.	NULL

46	NULL
.	NULL

47	NULL
.	NULL

48	NULL
.	NULL

49	NULL
.	NULL

50	NULL
.	NULL

51	NULL
.	NULL

52	NULL
.	NULL

53	NULL
.	NULL

3919	NULL
and	NULL
C	NULL
strains	NULL
of	NULL
herpesvirus	NULL
saimiri	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
88:7051-7055	NULL
.	NULL

Kaye	NULL
,	NULL
K.	NULL
M.	NULL
,	NULL
O.	NULL
Devergne	NULL
,	NULL
J.	NULL
N.	NULL
Harada	NULL
,	NULL
K.	NULL
M.	NULL
Izumi	NULL
,	NULL
R.	NULL
Yalamanchili	NULL
,	NULL
E.	NULL
Kieff	NULL
,	NULL
and	NULL
G.	NULL
Mosialos	NULL
.	NULL

1996	NULL
.	NULL

Tumor	NULL
necrosis	NULL
factor	NULL
receptor	NULL
associated	NULL
factor	NULL
2	NULL
is	NULL
a	NULL
mediator	NULL
of	NULL
NF-kB	NULL
activation	NULL
by	NULL
latent	NULL
infection	NULL
membrane	NULL
protein	NULL
1	NULL
,	NULL
the	NULL
Epstein-Barr	NULL
virus	NULL
transforming	NULL
protein	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
93:11085-11090	NULL
.	NULL

Koomey	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
C.	NULL
Mulder	NULL
,	NULL
R.	NULL
L.	NULL
Burghoff	NULL
,	NULL
B.	NULL
Fleckenstein	NULL
,	NULL
and	NULL
R.	NULL
C.	NULL
Desrosiers	NULL
.	NULL

1984	NULL
.	NULL

Deletion	NULL
of	NULL
DNA	NULL
sequences	NULL
in	NULL
a	NULL
nononcogenic	NULL
variant	NULL
of	NULL
herpesvirus	NULL
saimiri	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

50:662-665	NULL
.	NULL

Kretschmer	NULL
,	NULL
C.	NULL
,	NULL
C.	NULL
Murphy	NULL
,	NULL
B.	NULL
Biesinger	NULL
,	NULL
J.	NULL
Beckers	NULL
,	NULL
H.	NULL
Fickenscher	NULL
,	NULL
T.	NULL
Kirch-ner	NULL
,	NULL
B.	NULL
Fleckenstein	NULL
,	NULL
and	NULL
U.	NULL
Riither	NULL
.	NULL

1996	NULL
.	NULL

A	NULL
Herpes	NULL
saimiri	NULL
oncogene	NULL
causing	NULL
peripheral	NULL
T-cell	NULL
lymphoma	NULL
in	NULL
transgenic	NULL
mice	NULL
.	NULL

Oncogene	NULL
12:1609-1616	NULL
.	NULL

Lee	NULL
,	NULL
H.	NULL
,	NULL
J.	NULL
J.	NULL
Trimble	NULL
,	NULL
D.-W.	NULL
Yoon	NULL
,	NULL
D.	NULL
Regier	NULL
,	NULL
R.	NULL
C.	NULL
Desrosiers	NULL
,	NULL
and	NULL
J.	NULL
U.	NULL
Jung	NULL
.	NULL

1997	NULL
.	NULL

Genetic	NULL
variation	NULL
of	NULL
herpesvirus	NULL
saimiri	NULL
subgroup	NULL
A	NULL
transforming	NULL
protein	NULL
and	NULL
its	NULL
association	NULL
with	NULL
cellular	NULL
src	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

71:3817-3825	NULL
.	NULL

Lee	NULL
,	NULL
S.	NULL
Y.	NULL
,	NULL
A.	NULL
Reichlin	NULL
,	NULL
A.	NULL
Santana	NULL
,	NULL
K.	NULL
A.	NULL
Sokol	NULL
,	NULL
M.	NULL
C.	NULL
Nussenzweig	NULL
,	NULL
and	NULL
Y.	NULL
Choi	NULL
.	NULL

1997	NULL
.	NULL

TRAF2	NULL
is	NULL
essential	NULL
for	NULL
JNK	NULL
but	NULL
not	NULL
NF-kappaB	NULL
activation	NULL
and	NULL
regulates	NULL
lymphocyte	NULL
proliferation	NULL
and	NULL
survival	NULL
.	NULL

Immunity	NULL
7:703-713	NULL
.	NULL

Medveczky	NULL
,	NULL
P.	NULL
,	NULL
E.	NULL
Szomolayi	NULL
,	NULL
R.	NULL
C.	NULL
Desrosiers	NULL
,	NULL
and	NULL
C.	NULL
Mulder	NULL
.	NULL

1984	NULL
.	NULL

Classification	NULL
of	NULL
herpesvirus	NULL
saimiri	NULL
into	NULL
three	NULL
groups	NULL
based	NULL
on	NULL
extreme	NULL
variation	NULL
in	NULL
a	NULL
DNA	NULL
region	NULL
required	NULL
for	NULL
oncogenicity	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

52:938-944	NULL
.	NULL

Mittriicker	NULL
,	NULL
H.-W.	NULL
,	NULL
I.	NULL
Miller-Fleckenstein	NULL
,	NULL
B.	NULL
Fleckenstein	NULL
,	NULL
and	NULL
B.	NULL
Fleish-cher	NULL
.	NULL

1995	NULL
.	NULL

CD2-mediated	NULL
autocrine	NULL
growth	NULL
of	NULL
herpes	NULL
virus	NULL
saimiri-trans-formed	NULL
human	NULL
T	NULL
lymphocytes	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

176:900-913	NULL
.	NULL

Mosialos	NULL
,	NULL
G.	NULL
,	NULL
M.	NULL
Birkenbach	NULL
,	NULL
R.	NULL
Yal	NULL
hili	NULL
,	NULL
T.	NULL
VanArsdale	NULL
,	NULL
C.	NULL
Ware	NULL
,	NULL
and	NULL
E.	NULL
Kief	NULL
.	NULL

1995	NULL
.	NULL

The	NULL
Epstein-Barr	NULL
virus	NULL
transforming	NULL
protein	NULL
LMP1	NULL
engages	NULL
signaling	NULL
proteins	NULL
for	NULL
the	NULL
tumor	NULL
necrosis	NULL
factor	NULL
receptor	NULL
family	NULL
.	NULL

Cell	NULL
80:389-399	NULL
.	NULL

Murphy	NULL
,	NULL
C.	NULL
,	NULL
C.	NULL
Kretschmer	NULL
,	NULL
B.	NULL
Biesinger	NULL
,	NULL
J.	NULL
Beckers	NULL
,	NULL
J.	NULL
Jung	NULL
,	NULL
R.	NULL
C.	NULL
Desrosiers	NULL
,	NULL
H.	NULL
K.	NULL
Miiller-Hermelink	NULL
,	NULL
B.	NULL
W.	NULL
Fleckenstein	NULL
,	NULL
and	NULL
U.	NULL
Riither	NULL
.	NULL

1994	NULL
.	NULL

Epithelial	NULL
tumors	NULL
induced	NULL
by	NULL
a	NULL
herpesvirus	NULL
oncogene	NULL
in	NULL
transgenic	NULL
mice	NULL
.	NULL

Oncogene	NULL
9:221-226	NULL
.	NULL

Murthy	NULL
,	NULL
S.	NULL
C.	NULL
S.	NULL
,	NULL
J.	NULL
J.	NULL
Trimble	NULL
,	NULL
and	NULL
R.	NULL
C.	NULL
Desrosiers	NULL
.	NULL

1989	NULL
.	NULL

Deletion	NULL
mutants	NULL
of	NULL
herpesvirus	NULL
saimiri	NULL
define	NULL
an	NULL
open	NULL
reading	NULL
frame	NULL
necessary	NULL
for	NULL
transformation	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

63:3307-3314	NULL
.	NULL

Natoli	NULL
,	NULL
G.	NULL
,	NULL
A.	NULL
Costanzo	NULL
,	NULL
A.	NULL
Ianni	NULL
,	NULL
D.	NULL
J.	NULL
Templeton	NULL
,	NULL
J.	NULL
R.	NULL
Woodgett	NULL
,	NULL
C.	NULL
Balsano	NULL
,	NULL
and	NULL
M.	NULL
Levrero	NULL
.	NULL

1997	NULL
.	NULL

Activation	NULL
of	NULL
SAPK/JNK	NULL
by	NULL
TNF	NULL
receptor	NULL
1	NULL
through	NULL
a	NULL
noncytotoxic	NULL
TRAF2-dependent	NULL
pathway	NULL
.	NULL

Science	NULL
10:200-203	NULL
.	NULL

Nava	NULL
,	NULL
V.	NULL
E.	NULL
,	NULL
E.	NULL
H.-Y	NULL
.	NULL

Cheng	NULL
,	NULL
M.	NULL
Veliuona	NULL
,	NULL
S.	NULL
Zou	NULL
,	NULL
R.	NULL
J.	NULL
Clem	NULL
,	NULL
M.	NULL
L.	NULL
Mayer	NULL
,	NULL
and	NULL
J.	NULL
M.	NULL
Hardwick	NULL
.	NULL

1997	NULL
.	NULL

Herpesvirus	NULL
saimiri	NULL
encodes	NULL
a	NULL
functional	NULL
homolog	NULL
of	NULL
the	NULL
human	NULL
be/-2	NULL
oncogene	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

71:4118-4122	NULL
.	NULL

Rothe	NULL
,	NULL
M.	NULL
,	NULL
S.	NULL
C.	NULL
Wong	NULL
,	NULL
W.	NULL
J.	NULL
Henzel	NULL
,	NULL
and	NULL
D.	NULL
V.	NULL
Goeddel	NULL
.	NULL

1994	NULL
.	NULL

A	NULL
novel	NULL
family	NULL
of	NULL
putative	NULL
signal	NULL
transducers	NULL
associated	NULL
with	NULL
the	NULL
cytoplasmic	NULL
domain	NULL
of	NULL
the	NULL
75	NULL
kDa	NULL
tumor	NULL
necrosis	NULL
factor	NULL
receptor	NULL
.	NULL

Cell	NULL
78:681-692	NULL
.	NULL

Rother	NULL
,	NULL
R.	NULL
P.	NULL
,	NULL
S.	NULL
A.	NULL
Rollins	NULL
,	NULL
W.	NULL
L.	NULL
Fodor	NULL
,	NULL
J.-C.	NULL
Albrecht	NULL
,	NULL
E.	NULL
Setter	NULL
,	NULL
B.	NULL
Fleckenstein	NULL
,	NULL
and	NULL
S.	NULL
P.	NULL
Squinto	NULL
.	NULL

1994	NULL
.	NULL

Inhibition	NULL
of	NULL
complement-mediated	NULL
cytolysis	NULL
by	NULL
the	NULL
terminal	NULL
complement	NULL
inhibitor	NULL
of	NULL
herpesvirus	NULL
saimiri	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

68:730-737	NULL
.	NULL

Smith	NULL
,	NULL
C.	NULL
A.	NULL
,	NULL
T.	NULL
Farrah	NULL
,	NULL
and	NULL
R.	NULL
G.	NULL
Goodwin	NULL
.	NULL

1994	NULL
.	NULL

The	NULL
TNF	NULL
receptor	NULL
superfamily	NULL
of	NULL
cellular	NULL
and	NULL
viral	NULL
proteins	NULL
:	NULL
activation	NULL
,	NULL
costimulation	NULL
,	NULL
and	NULL
death	NULL
.	NULL

Cell	NULL
76:959-962	NULL
.	NULL

Song	NULL
,	NULL
H.	NULL
Y.	NULL
,	NULL
C.	NULL
H.	NULL
Regnier	NULL
,	NULL
C.	NULL
J.	NULL
Kirschning	NULL
,	NULL
D.	NULL
V.	NULL
Goeddel	NULL
,	NULL
and	NULL
M.	NULL
Rothe	NULL
.	NULL

1997	NULL
.	NULL

Tumor	NULL
necrosis	NULL
factor	NULL
(	NULL
TNF	NULL
)	NULL
-mediated	NULL
kinase	NULL
cascades	NULL
:	NULL
bifurcation	NULL
of	NULL
nuclear	NULL
factor-kappaB	NULL
and	NULL
c-jun	NULL
N-terminal	NULL
kinase	NULL
(	NULL
JNK/SAPK	NULL
)	NULL
pathways	NULL
at	NULL
TNF	NULL
receptor-associated	NULL
factor	NULL
2	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
94:9792-9796	NULL
.	NULL

Szomolanyi	NULL
,	NULL
E.	NULL
,	NULL
P.	NULL
Medveczky	NULL
,	NULL
and	NULL
C.	NULL
Mulder	NULL
.	NULL

1987	NULL
.	NULL

In	NULL
vitro	NULL
immortalization	NULL
of	NULL
marmoset	NULL
cells	NULL
with	NULL
three	NULL
subgroups	NULL
of	NULL
herpesvirus	NULL
saimiri	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

61:3485-3490	NULL
.	NULL

Takeuchi	NULL
,	NULL
M.	NULL
,	NULL
M.	NULL
Rothe	NULL
,	NULL
and	NULL
D.	NULL
V.	NULL
Goeddel	NULL
.	NULL

1996	NULL
.	NULL

Anatomy	NULL
of	NULL
TRAF2	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

271:19935-19942	NULL
.	NULL

Tartaglia	NULL
,	NULL
L.	NULL
A.	NULL
,	NULL
and	NULL
D.	NULL
V.	NULL
Goeddel	NULL
.	NULL

1992	NULL
.	NULL

Two	NULL
TNF	NULL
receptors	NULL
.	NULL

Immunol	NULL
.	NULL

Today	NULL
13:151-153	NULL
.	NULL

Thome	NULL
,	NULL
M.	NULL
,	NULL
P.	NULL
Schneider	NULL
,	NULL
K.	NULL
Hofmann	NULL
,	NULL
H.	NULL
Fickenscher	NULL
,	NULL
E.	NULL
Meinl	NULL
,	NULL
F.	NULL
Neipel	NULL
,	NULL
C.	NULL
Mattmann	NULL
,	NULL
K.	NULL
Burns	NULL
,	NULL
J.-L.	NULL
Bodmer	NULL
,	NULL
M.	NULL
Schroter	NULL
,	NULL
C.	NULL
Scaffidi	NULL
,	NULL
P.	NULL
H.	NULL
Krammer	NULL
,	NULL
M.	NULL
E.	NULL
Peter	NULL
,	NULL
and	NULL
J.	NULL
Tschopp	NULL
.	NULL

1997	NULL
.	NULL

Viral	NULL
FLICE-inhibitory	NULL
proteins	NULL
(	NULL
FLIPs	NULL
)	NULL
prevent	NULL
apoptosis	NULL
induced	NULL
by	NULL
death	NULL
receptors	NULL
.	NULL

Nature	NULL
386:517-521	NULL
.	NULL

Wang	NULL
,	NULL
C.	NULL
Y.	NULL
,	NULL
M.	NULL
W.	NULL
Mayo	NULL
,	NULL
R.	NULL
G.	NULL
Korneluk	NULL
,	NULL
D.	NULL
V.	NULL
Goeddel	NULL
,	NULL
and	NULL
A.	NULL
S.	NULL
J.	NULL
Baldwin	NULL
.	NULL

1998	NULL
.	NULL

NF-kappaB	NULL
antiapoptosis	NULL
:	NULL
induction	NULL
of	NULL
TRAF1	NULL
and	NULL
TRAF2	NULL
and	NULL
c-IAP1	NULL
and	NULL
c-IAP2	NULL
to	NULL
suppress	NULL
caspase-8	NULL
activation	NULL
.	NULL

Science	NULL
281:1680-1683	NULL
.	NULL

Yao	NULL
,	NULL
Z.	NULL
,	NULL
W.	NULL
C.	NULL
Fanslow	NULL
,	NULL
M.	NULL
F.	NULL
Seldin	NULL
,	NULL
A.	NULL
M.	NULL
Rousseau	NULL
,	NULL
S.	NULL
L.	NULL
Painter	NULL
,	NULL
M.	NULL
R.	NULL
Comeau	NULL
,	NULL
J.	NULL
I.	NULL
Cohen	NULL
,	NULL
and	NULL
M.	NULL
K.	NULL
Spriggs	NULL
.	NULL

1995	NULL
.	NULL

Herpesvirus	NULL
saimiri	NULL
encodes	NULL
a	NULL
new	NULL
cytokine	NULL
IL-17	NULL
,	NULL
which	NULL
binds	NULL
to	NULL
a	NULL
novel	NULL
cytokine	NULL
receptor	NULL
.	NULL

Immunity	NULL
3:811-821	NULL
.	NULL

Yao	NULL
,	NULL
Z.	NULL
,	NULL
E.	NULL
Maraskovsky	NULL
,	NULL
M.	NULL
K.	NULL
Spriggs	NULL
,	NULL
J.	NULL
I.	NULL
Cohen	NULL
,	NULL
R.	NULL
J.	NULL
Armitage	NULL
,	NULL
and	NULL
M.	NULL
R.	NULL
Alderson	NULL
.	NULL

1996	NULL
.	NULL

Herpesvirus	NULL
saimiri	NULL
open	NULL
reading	NULL
frame	NULL
14	NULL
,	NULL
a	NULL
protein	NULL
encoded	NULL
by	NULL
a	NULL
T	NULL
lymphotropic	NULL
herpesvirus	NULL
,	NULL
binds	NULL
to	NULL
MHC	NULL
class	NULL
II	NULL
molecules	NULL
and	NULL
stimulates	NULL
T	NULL
cell	NULL
proliferation	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

156:3260-3266.	NULL
.	NULL

Yuasa	NULL
,	NULL
T.	NULL
,	NULL
S.	NULL
Ohno	NULL
,	NULL
J.	NULL
H.	NULL
Kehrl	NULL
,	NULL
and	NULL
J.	NULL
M.	NULL
Kyriakis	NULL
.	NULL

1998	NULL
.	NULL

Tumor	NULL
necrosis	NULL
factor	NULL
signaling	NULL
to	NULL
stress-activated	NULL
protein	NULL
kinase	NULL
(	NULL
SAPK	NULL
)	NULL
/Jun	NULL
NH	NULL
,	NULL
-terminal	NULL
kinase	NULL
(	NULL
JNK	NULL
)	NULL
and	NULL
p38	NULL
.	NULL

Germinal	NULL
center	NULL
kinase	NULL
couples	NULL
TRAF2	NULL
to	NULL
mitogen-activated	NULL
protein	NULL
kinase/ERK	NULL
kinase	NULL
kinase	NULL
1	NULL
SAPK	NULL
while	NULL
receptor	NULL
interacting	NULL
protein	NULL
associates	NULL
with	NULL
a	NULL
mitogen-activated	NULL
protein	NULL
kinase	NULL
kinase	NULL
kinase	NULL
upstream	NULL
of	NULL
MKK6	NULL
and	NULL
p38	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

273:22681	NULL
.	NULL

